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ABSTRACT	  	  	  The	   work	   of	   this	   thesis	   was	  mainly	   focused	   on	   the	   transcriptional	   effects	   of	   two	  strong	   and	   highly	   specific	   transcription	   inhibitors:	   Triptolide	   and	   Campthotecin.	  The	   two	   compounds	   are	   both	   natural	   products	   derived	   from	   Chinese	   medicinal	  plants.	  Although	  with	  completely	  different	  molecular	  targets,	  these	  two	  drugs	  show	  interesting	   properties	   such	   as	   anti-­‐proliferative	   and	   anti-­‐tumor	   activity.	  Additionally,	  these	  two	  drugs,	  as	  selective	  inhibitors	  of	  their	  targets	  (XPB	  and	  Top1	  respectively),	   can	   be	   used	   to	   dissect	   the	   role	   of	   these	   proteins	   in	   transcriptional	  regulation.	  Triptolide	  (TPL)	  is	  a	  diterpene	  epoxide	  derived	  from	  the	  Chinese	  plant	  Trypterigium	  
Wilfoordii	   Hook	   F.	   This	   compound	   shows	   great	   immunosuppressive,	   anti-­‐inflammatory	   and	   anti-­‐proliferative	   activities,	   mainly	   due	   to	   its	   strong	  transcriptional	   inhibitory	   property.	   TPL	   inhibits	   the	   ATPase	   activity	   of	   XPB,	   a	  subunit	   of	   the	   general	   transcription	   factor	   TFIIH.	   One	   of	   the	   most	   relevant	  consequences	  of	  TPL	  treatments	  is	  the	  degradation	  of	  RNA	  Polymerase	  II	  in	  a	  dose	  and	   time-­‐dependent	  manner.	   In	   this	   thesis	   I	   found	   that	   degradation	   of	   Rbp1	   (the	  largest	   subunit	   of	   RNA	   Polymerase	   II)	   during	   TPL	   treatments,	   is	   preceded	   by	   an	  hyperphosphorylation	   event	   at	   serine	   5	   of	   the	   carboxy-­‐terminal	   domain	   (CTD)	   of	  Rbp1.	  	  This	  event	  is	  concomitant	  with	  a	  block	  of	  RNA	  Polymerase	  II	  at	  promoters	  of	  active	  genes.	  The	  enzyme	  responsible	  for	  Ser5	  hyperphosphorylation	  event	  is	  CDK7.	  Notably,	  CDK7	  downregulation	  rescued	  both	  Ser	  5	  hyperphosphorylation	  and	  Rbp1	  degradation	   triggered	   by	   TPL.	   Our	   data	   therefore	   clarify	   novel	   aspects	   of	   the	  transcriptional	   role	   of	   TFIIH	   and	   show	   how	   this	   complex	   can	   regulate	   RNA	  Polymerase	  II	  stability.	  	  Differently	   from	   TPL	   that	   is	   currently	   used	   in	   clinical	   trials	   for	   treating	   cancer,	  camptothecin	   (CPT)	   is	   an	   already	   FDA-­‐approved	   drug	   highly	   effective	   in	   the	  treatment	   of	   solid	   tumors	   such	   as	   ovarian	   and	   colon	   cancers.	   CPT	   specifically	  inhibits	   topoisomerase	   1	   (Top1).	   This	   enzyme	   is	   able	   to	   remove	   torsional	   stress	  created	   by	   physiological	   processes	   such	   as	   transcription	   and	   replication.	   Top1	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introduces	  a	  nick	  in	  the	  DNA	  molecule	  and	  covalently	  binds	  it,	  allowing	  a	  controlled	  rotation	  of	  the	  cut	  strand	  around	  the	  uncut	  strand	  that	  removes	  the	  torsional	  stress.	  Top1	   is	   able	   to	   relax	  both	  overwound	  and	  underwound	  DNA,	  usually	   indicated	  as	  positive	   and	   negative	   supercoiled	   DNA,	   respectively.	   CPT	   can	   interfere	   with	   this	  process	  by	  blocking	  and	  stabilizing	  Top1	  on	  DNA	  leading	  to	  a	   formation	  of	  a	  Top1	  
cleavage	  complex	  (Top1cc).	  	  In	  this	  work,	  I	  revealed	  new	  important	  effects	  that	  CPT-­‐induced	  Top1ccs	  have	  on	  transcription.	  We	  first	   found	  that	  CPT	  induced	  antisense	  transcription	   at	   divergent	   CpG	   islands	   promoter.	   Notably,	   this	   phenomenon	   is	  independent	  from	  replication,	  but	  depends	  on	  both	  Top1	  and	  CDK9	  kinase	  activity.	  Interestingly,	  by	  immunofluorescence	  experiments,	  CPT	  was	  found	  to	  induce	  a	  burst	  of	   R	   loop	   structures	   (non	   B-­‐DNA	   structures	   composed	   by	   DNA/RNA	   hybrids	  stabilized	  by	  negative	  supercoils)	  at	  highly	  transcribed	  regions	  such	  as	  nucleoli	  and	  mitochondria.	   In	   collaboration	   with	   Frederic	   Chedin’s	   lab,	   we	   tried	   to	  immunoprecipitate	   R	   loop	   structures	   after	   CPT	   treatments.	   Unfortunately,	   after	  drug	  treatment,	  these	  structures	  resulted	  highly	  unstable	  and	  difficult	  to	  isolate.	  We	  then	  decided	  to	  investigate	  the	  role	  of	  Top1	  in	  R	  loop	  homeostasis	  through	  a	  short	  interfering	  RNA	  approach	  (RNAi).	  Using	  DNA/RNA	  immunoprecipitation	  techniques	  coupled	   to	   next	   generation	   sequencing	   I	   found	   that	   Top1	   depletion	   induces	   an	  increase	  of	  R	  loops	  at	  a	  genome-­‐wide	  level.	  We	  found	  that	  such	  increase	  occurs	  on	  the	  entire	  gene	  body	  and	  involves	  both	  a	  spreading	  and	  an	  increase	  in	  frequency	  of	  R	   loops.	   	   At	   a	   subset	   of	   loci	   R	   loops	   resulted	   particularly	   stressed	   after	   Top1	  depletion.	  Notably	  these	  loci	  were	  frequently	  part	  of	  really	   long	  genes	  (>50	  kb),	   in	  agreement	  with	  the	  role	  that	  Top1	  has	  in	  regulating	  transcription	  and	  supercoils	  of	  very	  long	  genes.	  Interestingly,	  some	  of	  these	  genes	  showed	  the	  formation	  of	  new	  R	  loops	  structures	  (gain	  of	  R	  loop	  peaks),	  whereas	  other	  loci	  showed	  a	  reduction	  of	  R	  loops	   (loss	   of	   peaks).	   Interestingly	  we	   found	   that	   gain	   of	   peaks	   usually	   occurs	   at	  tandem	  or	  divergent	  genes	  in	  the	  entire	  gene	  body,	  while	  loss	  of	  R	  loop	  peaks	  seems	  to	  be	   a	   feature	   specific	   of	   3’	   end	   regions	   of	   convergent	   genes.	  RNA	   seq	   and	  PolII-­‐ChIP-­‐seq	   revealed	   that	   only	   loci	   having	   loss	   of	   R	   loop	   peaks	   also	   showed	   an	  impairment	   of	   PolII	   progression	   and	   transcriptional	   termination.	   Thus	   our	   data	  revealed	  new	  and	  unexpected	  transcriptional	  role	   for	  Top1.	  Moreover	  we	  clarified	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Chapter	  I	  
	  
INTRODUCTION	  	  	  Natural	  products	   from	  medicinal	  plants	  have	  always	  attracted	   the	  attention	  of	   the	  scientific	   community	   due	   to	   their	   many	   biological	   properties	   that	   make	   these	  compounds	  effective	   in	   treating	  several	  diseases	  such	  as	  cancer	  and	   inflammatory	  and	   auto-­‐immune	   disorders.	   Among	   the	   thousand	   of	   compounds	   isolated	   from	  different	   plants	   and	   organisms	   transcriptional	   inhibitors	   are	   among	   the	   most	  effective	   in	   treating	   many	   disorders.	   Moreover,	   as	   the	   specific	   target	   of	   some	   of	  them	  is	  known,	  then	  those	  compounds	  can	  be	  used	  as	  a	  powerful	  tool	  	  to	  investigate	  transcriptional	   mechanisms	   and	   allow	   us	   to	   understand	   the	   physiological	   and	  pathological	  role	  of	  the	  investigated	  proteins.	  	  
	  
	  
1.1	  	  Transcription	  and	  transcriptional	  inhibitors:	  from	  classic	  	  
	  	  	  	  	  	  	  	  	  compounds	  to	  Triptolide	  
	  
	  
1.1.1	  RNA	  Polymerase	  and	  transcription.	  	  The	   transcriptional	   process	   is	   an	   essential	   mechanism	   for	   every	   living	   organism.	  This	   process	   consists	   of	   a	   synthesis	   of	   an	   RNA	   molecule	   (a	   structure	   with	   a	  ribose/phosphate	   skeleton)	   starting	   from	   a	   DNA	   molecule	   as	   template.	   The	   new	  synthetized	  RNA	  can	   represent	   the	   intermediate	  between	  genetic	   information	  and	  biological	  effectors	  as	  proteins,	  or	  alternatively	  can	  constitute	  a	  biological	  effector	  itself.	  The	  enzyme	  able	  to	  catalyze	  the	  synthesis	  of	  RNA	  from	  a	  DNA	  template	  is	  the	  RNA	  Polymerase.	   Particularly	   the	   enzyme	   catalyzes	   the	   formation	   of	   covalent	  phopshodiesteric	  bonds	  between	  the	  3’	  OH	  of	  a	  ribose	  sugar	  ring	  and	  a	  phosphate	  group	  in	  5’	  position	  of	  the	  following	  ribose,	  trough	  the	  removal	  of	  a	  pyrophosphate	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group	  from	  the	  new	  triphosphate	  ribonucleoside	  that	  is	  being	  incorporated	  into	  the	  nascent	  RNA	  molecule.	  Eukaryotes	  possess	  three	  different	  RNA	  Polymerases:	  I,	  II	  and	  III.	  	  1) RNA	   Polymerase	   I	   synthetizes	   the	   precursor	   of	   ribosomal	   RNA,	   that	   is	  processed	  into	  rRNA	  28S,	  18S	  and	  5.8S.	  These	  RNAS	  have	  a	  structural	  role	  in	  ribosome	   biogenesis,	   therefore	   RNA	   Polymerase	   III	   activity	   is	   intimately	  linked	  to	  cell	  growth	  and	  proliferation	  (1)	  	  2) RNA	   Polymerase	   II	   synthetizes	   the	   heterogeneous	   nuclear	   RNA	   (hnRNA)	  precurosor	  of	   the	  protein-­‐coding	  mRNA,	   the	   regulatory	  short	  nuclear	  RNAs	  (snRNAs)	  and	  the	  long	  non	  codings	  RNA	  (lncRNAs)	  (2)	  3) RNA	   Polymerase	   III	   synthetized	   tRNAs,	   rRNA	   5S,	   snRNA	   U6	   (involved	   in	  splicing),	  RNA	  7SL	   (involved	   in	   secretion	  proteins	   synthesis)	   and	   the	   small	  RNA	  7SK	  (inhibitor	  of	  the	  P-­‐TEFb	  elongating	  factor).	  (3)	  	  
	  
	  
1.1.2	  RNA	  Polymerase	  II,	  CTD	  and	  transcription	  phases	  Altough	   RNA	   Polymerase	   I	   and	   III	   play	   essential	   role	   for	   cell	   proliferation	   and	  growth,	  transcription	  mediated	  by	  RNA	  Polymerase	  II	  produces	  the	  major	  variety	  of	  transcripts	   and	   its	   activity	   is	   probably	   the	  most	   tightly	   regulated.	   For	   this	   reason	  PolII	  mediated	  transcription	  was	  deeply	  investigated	  in	  the	  last	  twenty	  years.	  RNA	  Polymerase	  II	  is	  a	  protein	  complex	  consisting	  of	  12	  subunits	  (composition	  valid	  for	  both	  human	  and	  yeast	  homologues	  )	  (4)	  The	   most	   important	   feature	   of	   RNA	   Polymerase	   II	   (PolII)	   that	   characterizes	   and	  differentiates	   this	   polymerase	   from	   the	   other	   ones	   is	   the	   presence	   of	   a	   long	   and	  flexible	  carboxyl	  terminal	  domain	  (CTD)	  of	  	  the	  largest	  subunit	  RPB1.	  This	  domain	   consists	  of	  multiple	   	   heptarepeats	   (Y1S2P3T4S5P6S7)	   that	   are	   target	  of	  different	   post-­‐translational	   modifications	   during	   the	   transcriptional	   cycle.	   The	  importance	   of	   this	   component	   can	   be	   understood	   if	   we	   compare	   its	   length	   with	  complexity	   of	   genomes:	   the	   larger	   is	   the	   genome	   the	   longer	   is	   the	   CTD	   (26	  heptarepeats	  in	  S.	  cerevisiae,	  32	  in	  C.	  elegans,	  45	  in	  Drosophila,	  and	  52	  in	  mammals)	  
	   	   6	  
(5)(6).	   These	   sequences	   are	   target	   of	   different	   kinases	   and	   phosphatases	   that	  regulate	  CTD	  and	  RNA	  polymerase	  functions	  during	  transcription.	  RNA	  Polymerase	  II-­‐mediated	  transcription	  is	  a	  highly	  regulated	  process,	  that	  consist	  of	  multiple	  crucial	  steps:	  1) Pre-­‐initiation	  complex	  (PIC)	  nucleation:	  RNA	  Polymerase	  II	  associates	  with	  general	  transcription	  factors	  (GTFs)	  to	  form	  the	  PIC	  at	  the	  correct	  position	  on	  on	   promoter.	   GTFs	   have	   been	   widely	   studied	   and	   characterized.	   The	   first	  actor	   is	   TFIID.	   This	   complex	   composed	   by	   TBP	   (TATA	  binding	  protein)	  and	  TAFs	  (TBP-­‐associated	  factors)	  is	  the	  core	  of	  the	  PIC	  and	  its	  binding	  to	  DNA	  is	  essential	  for	  a	  correct	  nucleation	  of	  the	  complex.	  TFIID	  is	  helped	  by	  TFIIA	  to	  recognize	   the	  promoter	  sequences.	  TFIIB	  stabilizes	   the	   interaction	  between	  TFIID	   and	   PolII-­‐TFIIF	   (7).	   The	   latter	   is	   able	   to	   associate	   tightly	   to	   the	  polymerase	   allowing	   the	   interaction	   with	   TFIID/IIA/IIB	   (8).	   TFIID,	   once	  bound	   to	   DNA	   with	   the	   other	   factors	   of	   PIC,	   interacts	   via	   TAFs	   with	   the	  transcriptional	  co-­‐activator	  Mediator.	  This	  important	  complex	  recognizes	  the	  unphosphorylated	   CTD	   of	   RNA	   Polymerase	   II	   favoring	   the	   polymerase	  loading	  to	  the	  DNA.	  	  2) Promoter	   clearance:	   The	   Mediator	   complex,	   after	   binding	   to	   the	  unphosphorylated	   CTD	   cooperates	   with	   TFIIE	   to	   strongly	   stimulate	   the	  kinase	   activity	   of	   TFIIH	   on	   the	   CTD	   itself.	   	   The	   complex	   is	   crucial	   for	   	   the	  promoter	  clearance	  of	  PolII	  and	  the	  transition	  from	  the	  pre-­‐initiation	  step	  to	  the	   initiation	  phase	   (9).	  TFIIH	   is	  a	  complex	  composed	  of	   ten	  subunits:	   	  one	  core	   complex	   composed	  by	  XPD,	  XPB,	  p62,	  p52,	  p44,	  p34	  and	  TTDA;	   and	  a	  cyclin	  dependent	  sub-­‐complex	  composed	  by	  CDK7,	  MAT1	  and	  cyclin	  H.	  	  The	  former	  is	  responsible	  of	  the	  melting	  of	  promoter	  and	  formation	  of	  	  the	  open	  
complex	   trough	   the	  ATPase	   activity	   of	   XPB	  (10),	   the	   latter	   favors	  promoter	  
escaping	   by	   phosphporylating	   	   Ser5	   on	   CTD	   of	   PolII	   via	   CDK7.	   This	  modification	  commits	  RNA	  Polymerase	  II	  to	  a	  more	  processive	  synthesis	  and	  at	  same	  time	  leads	  to	  dissociation	  of	  Mediator	  complex	  from	  PolII	  CTD	  (11).	  Particularly,	   it	   has	   been	   shown	   that	   levels	   of	   Ser5	   remain	   high	   during	   the	  synthesis	   of	   first	   hundreds	   of	   nucleotides	   and	   then	   decline	   further	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downstream	  the	  genes	  (12).	  During	  the	  initiation	  phase	  synthesis	  of	  the	  RNA	  molecule	   is	   an	   inefficient	   process	   that	   can	   easily	   be	   concluded	   with	  premature	  termination	  and	  transcription	  abortion.	  At	  this	  step,	  there	  is	  a	  sort	  of	   equilibrium	   between	   premature	   termination	   and	   productive	   RNA	  synthesis	   and	   by	   phosphorylating	   Ser5,	   TFIIH	   shifts	   this	   equilibrium	  therefore	   suppressing	   this	   instability.	  The	  presence	  of	  TFIIF	   enhances	   also.	  This	   process.	   For	   this	   reason	  TFIIH	   and	   IIF	   can	   be	   considered	   at	   the	   same	  time	  both	  initiation	  and	  elongation	  factors.	  (6).	  3) Pausing	  and	  elongation:	  Once	  the	  RNA	  chain	  reaches	  the	  length	  of	  about	  15	  nucleotides	   the	   initiation	   complex	   become	   stable	   and	   the	   risk	   of	  transcriptional	  abortion	  dramatically	  decreases.	  At	  this	  step	  RNA	  polymerase	  II	  usually	  does	  not	  enter	  in	  a	  productive	  RNA	  extension,	  instead	  remaining	  in	  a	  paused	  conformation.	  	  In	  this	  conformation	  PolII	  activity	  is	  highly	  regulated	  by	  positive	  and	  negative	  elongation	  factor	  that	  can	  modulate	  processivity	  of	  polymerase.	  The	  most	  important	  factors	  that	  regulate	  pausing	  and	  elongation	  of	   PolII	   are	   P-­‐TEF-­‐b	   (Positive	   Transcriptional	   Elongation	   Factor	   b)	   and	  DSIF/NELF	  complex.	  P-­‐TEFb	  is	  a	  cyclin-­‐dependent	  CTD	  kinase	  composed	  of	  Cdk9	  and	  one	  of	  several	  cyclins	  including	  T1,	  T2	  and	  K	  (13).	  This	  important	  factor	  usually	  phosphorylates	  the	  CTD	  of	  PolII	  at	  level	  of	  Ser2	  promoting	  the	  release	   of	   polymerase	   from	   pausing	   site	   and	   allowing	   a	   productive	  elongation.	  CTD	  phosphorylation	  by	  P-­‐TEFb	  is	  required	  to	  prevent	  arrest	  of	  elongating	  pol	  II.	  	  DSIF	  (DRB	  sensitivity	  inducing	  factor)	  and	  NELF	  (negative	  elongation	   factor)	   cooperate	   to	   bind	   PolII-­‐CTD	   and	   preventing	   elongation	  inducing	   transcriptional	   arrest.	   By	   phosphorylating	   Ser2,	   P-­‐TEFb	   impedes	  the	   association	   of	   the	   negative	   complex	   DSIF/NELF	   to	   the	   CTD	   of	   RNA	  Polymerase	   II,	   thus	   favoring	   the	  elongation.	  Additionaly,	   it	  has	  been	  shown	  that	   P-­‐TEFb	   also	   catalyzes	   the	   phosphorylation	   of	   hSpt5,	   subunit	   of	   DSIF	  promoting	  the	  disruption	  of	  DSIF/NELF	  complex	  (14).	  In	  in	  vitro	  experiments	  Rna	  Polymerase	  II	  is	  able	  to	  catalyze	  the	  synthesis	  of	  RNA	  with	  a	  rate	  of	  100-­‐300	   nucleotides/minute.	   The	   in	   vivo	   rate	   is	   instead	   dramatically	   higher:	  1500nt/minute.	   This	   notable	   increase	   is	   basically	   due	   to	   the	   presence	   of	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different	   elongation	   factors	   that	   stimulate	   the	   processivity	   of	   PolII.	   These	  proteins	   can	   prevent	   pausing	   of	   PolII	   during	   transcription	   or	   alternatively	  reactivate	  and	  arrested	  polymerase:	  
-­‐ TFIIF,	  even	  if	  considered	  as	  an	  initiation	  factor,	  this	  protein	  is	  able	  to	  re-­‐associate	   to	   the	   transcription	   elongation	   complex	   (TEC)	   when	   Pol	   II	   is	  stalled	  (15)	  
-­‐ Elongin	   complex,	   it’s	   a	   complex	   able	   to	   suppress	   PolII	   pausing	   trough	  realignment	   of	   the	   3’OH	   of	   the	   nascent	   transcript	   misaligned	   in	   the	  catalytic	  site	  of	  an	  arrested	  PolII.	  	  
-­‐ ELL	   family,	   similarly	   to	   the	   previous	   two	   complexes	   these	   proteins	   can	  suppress	  PolII	  pausing,	  particularly	  at	  really	  long	  genes.	  
-­‐ CSB	  (Cockayne	  Syndrome	  B)	  protein	  involved	  in	  TC-­‐NER	  able	  to	  stimulate	  and	  reactivate	  a	  stalled	  Pol	  II	  in	  proximity	  of	  a	  DNA	  lesion.	  
-­‐ TFIIS,	   this	   factor	   stimulates	   intrinsic	   endonucleasic	   activity	   of	   PolII	  allowing	   cleavage	   of	   the	   nascent	   transcript	   and	   the	   creation	   of	   a	   new	  3’OH	   in	   the	   RNA	   chain	   correctly	   aligned	   in	   the	   catalytic	   site	   (16).	   This	  factor	  contributes	  to	  the	  proof	  reading	  activity	  of	  PolII.	  There	  are	  also	  other	  proteins	  that	  can	  affect	  elongation	  of	  RNA	  Polymerase	  II,	  even	  if	  they	  are	  not	  properly	  elongation	  factors.	  	  Notably	  RNA	  Polymerase	  II	  has	  to	  deal	  with	  a	  complicated	  “architectural	  complex”	  such	  as	  chromatin.	  As	  nucleosomes	   basically	   act	   to	   repress	   transcription,	   chromatin	   remodeling	  factors	   and	   histone	   modifiers	   can	   affect	   PolII	   elongation.	   Among	   the	  chromatin	  remodeling	  factors	  we	  can	  find:	  SWI/SNF,	  CHD1,	  FACT	  and	  hSpt6.	  Many	   of	   them	   are	   able	   to	   remove	   nucleosome	   during	   PolII	   elongation.	   As	  regards	   epigenetic	   modifiers	   the	   most	   important	   are	   Elongator,	   Set2,	   Set1	  and	   PAF	   complex.	   They	   usually	   interact	   with	   the	   phosphorylated	   CTD	  triggering	  histonic	  modifications	  (acetylation,	  H3K4	  methylation)	  that	  induce	  an	  open	  state	  of	  chromatin.	  4) Termination:	   this	   process	   occurs	   when	   PolII	   decreases	   progressively	   its	  productivity,	   therefore	   interrupting	   the	   synthesis	   of	   RNA.	   Termination	  usually	  occurs	  co-­‐trascriptionally	  trough	  recognition	  of	  sequences	  located	  at	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3’	  end	  of	  transcript	  that	  can	  act	  in	  cis.	  In	  yeast	  we	  can	  distinguish	  two	  kind	  of	  termination:	  
-­‐ PolyA-­‐dependent	   termination:	   According	   to	   the	   torpedo	   model	   a	   polyA	  signal	   located	  at	  3’	  end	  of	  gene	   is	   first	   transcribed	  by	  PolII.	  The	   latter	   is	  then	  paused	  and	  the	  nascent	  transcript	  is	  cleaved.	  The	  upstream	  cleavage	  product	   is	   polyadenilated,	   while	   the	   downstream	   cleavage	   product	   is	  degraded.	  The	  3’	  end	  processing	  reaction	  starts	  when	  the	  AAUAAA	  signal	  present	   in	   the	  nascent	  RNA	  molecule	   is	   recognized	  by	   the	   cleavage	   and	  polyadenilation	   factor	   CPF	   through	   the	   interaction	   with	   PolII	   body,	  therefore	   inducing	   PolII	   stalling.	   Immediately	   later,	   the	   cleavage	  stimulatory	   factor	   CF1A	   recognizes	   a	   GU	   rich	   element	   downstream	   of	  polyA	   site,	   recruits	   CPF,	   thus	   releasing	   its	   hold	   on	   PolII	   body.	   CPF	  accompanied	   CF1A	   to	   the	   PolII-­‐CTD	   and	   the	   latter	   enhance	   cleavage	  reaction	  performed	  by	   the	   former,	   therefore	   allowing	   release	  of	  paused	  PolII.	  An	  efficient	  release	  of	  PolII	  pause	  can	  occur	  only	  in	  the	  presence	  of	  a	   5’-­‐3’	   exoribonuclease	   Rat1	   in	   complex	   with	   Rai1	   and	   Rtt103,	   this	  complex	   is	   able	   to	   recognize	   the	   unprotected	   5’	   end	   generated	   by	   the	  cleavage	  reaction	  allowing	   the	  degradation	  of	   the	  RNA	  coming	  out	   from	  the	  exit	   channel	  of	  PolII.	  Collision	  of	  Rat1	  with	  PolII	   eventually	   leads	   to	  termination.	  (17)	  
-­‐ Sen1-­‐dependent	  termination:	  this	  mechanism	  regards	  the	  processing	  of	  3’	  end	  of	  snRNA	  (short	  nuclear	  RNA)	  and	  snoRNA	  (small	  nucleolar	  RNA),	  but	  not	   mRNA.	   The	   molecular	   actors	   in	   this	   pathway	   are	   different:	   the	  reaction	  cleavage	  is	  performed	  by	  the	  nuclear	  exosome	  TRAMP	  complex,	  Nrd1	   and	   Nab3	   bind	   RNA	   and	   the	   putative	   RNA/DNA	   helicase	   Sen1	  promote	   termination	   by	   unwinding	   the	   RNA/DNA	   hybrid	   in	   the	   active	  site	  of	  PolII.(18)	  	  	  	  	  	  	  	  	  	  	  	  	  As	   regards	  mammals,	   the	   termination	  mechanism	   involves	   recognition	   of	   a	  polyadenilation	   signal	   (PAS).	   	  Most	  part	  of	  protein	   involved	   in	   this	  pathway	  are	  the	  human	  homologs	  of	  the	  yeast	  pathway	  (hCPSF	  for	  CPF,	  hCstF	  for	  CF1A,	  hXRN2	   for	   Rat1).	   Although	   for	   some	   mammalian	   genes,	   a	   functional	   PAS	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signal	   is	   sufficient	   for	   an	   efficient	   termination,	   for	   many	   others	   additional	  sequences	  are	  required.	  In	  mammals	  two	  kind	  of	  additional	  terminators	  have	  been	  identified	  involving	  two	  different	  termination	  mechanisms:	  
-­‐ Pause	  element	  terminators:	  these	  regions	  are	  located	  downstream	  of	  the	  	  	  	  PAS	  and	  are	  usually	  G	  rich.	  At	   level	  of	   this	  region	  the	  nascent	  transcript	  form	   RNA/DNA	   hybrid	   structures	   called	   R	   loops,	   probably	   inducing	   a	  slow	   down	   of	   PolII.	   Senataxin	   (human	   homolog	   of	   Sen1)	   subsequently	  resolves	   these	   structures.	  This	   allows	  access	  of	  XRN2	  at	  polyA	   cleavage	  sites,	  3’	  transcript	  degradation	  and	  PolII	  termination	  (19)	  -­‐	   	   	   Co-­‐Transcriptional	   cleavage	   terminators	   (CoTC):	   In	   this	   mechanism	   the	  cleavage	   to	   create	   an	   entry	   site	   for	   XRN2	   does	   not	   occur	   at	   PAS	   but	   at	  region	  called	  CoTC	  element.	  Degradation	  at	  3’	  end	  of	  RNA	  is	  performed	  by	  XRN2	  and	  this	  lead	  to	  release	  of	  PolII	  from	  chromatin	  template	  with	  pre-­‐mRNA	  associated.	   Subsequently	  PAS	   cleavage	   induces	  dissociation	   from	  PolII.	  (20)	  It	   is	   not	   clear	   if	   in	  mammals	   there	   is	   a	  PAS	   indipedent	  mechanism	   like	   that	  onevalid	  for	  snoRNA	  in	  yeast.	  	  
	  
	  
Fig1.	  Transcriptional	  steps	  and	  regulation	  of	  CTD-­‐phosphorylation.	  Figure	  from	  	  Unravelling	  the	  means	  to	  an	  end:	  RNA	  polymerase	   II	   transcription	   termination.	   Jason	  N.	   Kuehner,	   Erika	  L.	   Pearson	   and	   Claire	  Moore.	  Nature	  Reviews	  Molecular	  and	  Cellular	  Biology,	  May	  2011	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1.1.3	  Principal	  transcriptional	  inhibitors	  	  The	  above-­‐mentioned	  steps	  of	  transcription	  have	  been	  deeply	  investigated	  and	  well	  characterized.	   	  One	   important	   tool,	  used	  to	  understand	  the	  molecular	  mechanisms	  underlying	  the	  transcriptional	  process,	  came	  from	  the	  use	  of	  specific	  transcriptional	  inhibitors.	  These	  compounds,	   frequently	  purified	  as	  natural	  products	   from	  several	  plants	  or	  fungi,	  were	  often	  used	  as	  potent	  anti	  proliferative	  agents.	  Some	  of	  them	  are	  used	  as	  chemotherapic	  agents	  in	  FDA-­‐approved	  therapies	  or	  they	  are	  currently	  used	  in	  clinical	   trials.	  Once,	   their	  specific	   targets	  have	  been	   identified	   these	  compounds	  became	  powerful	  tools	  to	  investigate	  molecular	  mechanisms.	  
	  
a-­‐Amanitin	  Alpha-­‐Amanitin	   is	  one	  of	   the	  most	  powerful	   transcriptional	   inhibitors.	   It’	   s	  a	   toxin	  derived	   from	   fungi	   that	   are	   part	   of	   gender	  Amanita	   (A.	  phalloides,	  A.	   bisporigera).	  This	   compound	   is	   able	   to	   inhibit	   both	   RNA	   polymerase	   II	   and	   III,	   even	   if	   with	  different	  sensitivity.	  The	  most	  sensitive	  enzyme	  is	  RNA	  Polymerase	  II	  that	  shows	  an	  IC50	  of	  0,02	  mg/ml,	  while	  for	  RNA	  Polymerase	  III	  this	  value	  increase	  of	  about	  	  100-­‐folds.	   Instead,	  RNA	  Polymerase	  I	   is	  not	  sensitive	  to	  this	  drug	  (21).	  Alpha-­‐Amanitin	  binds	  in	  a	  pocket	  really	  close	  to	  the	  “bridge	  helix”	  responsible	  for	  the	  translocation	  of	   RNA	   Polymerase	   during	   the	   synthesis	   of	   the	   RNA	   molecule.	   One	   of	   the	   main	  molecular	   effect	   of	   a-­‐Amanitin	   is	   the	   degradation	   of	   Rbp1,	   the	   largest	   subunit	   of	  RNA	  Polymerase	  II,	  without	  affecting	  stability	  of	  other	  subunits	  (Rpb5	  and	  8).	   	  The	  degradation	  of	  Rbp1	  could	  explain	  the	  irreversible	  effect	  of	  alpha-­‐amanitin.	  (22).	  	  
Actinomycin	  D	  
Actinomycin	  D	  	  is	  an	  antibiotic	  polypeptide	  produced	  by	  bacteria	  Streptomyces.	  It’s	  a	  really	   strong	   transcriptional	   inhibitor.	   It	   was	   one	   of	   the	   most	   common	  chemotherapic	   drug,	   used	   to	   treat	   different	   kinds	   of	   cancer.	   Now	   it	   has	   been	   put	  aside	   from	   current	   chemoterapic	   protocols,	   because	   of	   its	   elevated	   cytotoxicity.	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Transcription	   by	   all	   three	   eukaryotic	   polymerases	   is	   usually	   affected	   during	  Actinomycin	   treatment,	   even	   if	   with	   different	   sensitivities.	   The	   most	   sensitive	   is	  RNA	  	  Polymerase	  I	  mediated	  transcription,	  while	  the	  least	  is	  transcription	  mediated	  by	   RNA	   Polymerase	   III.	   Actinomycin	   is	   an	   intercalating	   agent	   that	   preferentially	  binds	   GC	   rich	   sequences.	   It’s	   also	   able	   to	   inhibit	   DNA	   topoisomerase-­‐I	   probably	  impeding	   RNA	   polymerase	   progression.	   Actinomycin	   D	   generates	   DNA	   double-­‐strand	   breaks	   marked	   also	   by	   phosphorylation	   of	   histone	   H2AX.	   Transcriptional	  inhibition	   seems	   to	   be	   reversible.	   Actinomycin	   induces	   hyperphosphorylation	   of	  CTD	  of	  PolII	  likely	  trough	  hyperactivation	  of	  P-­‐TEFb.(23)	  
	  
Flavopiridol	  and	  DRB	  These	   two	   compounds	   can	   be	  mainly	   classified	   as	   CDK9	   inhibitors.	   Several	   drugs	  can	  be	  included	  in	  this	  category,	  and	  a	  unique	  mechanism	  of	  action	  is	  shared	  among	  them:	   competition	   with	   ATP	   for	   the	   kinase	   active	   site.	   Since	   several	   cyclin-­‐dependent	  kinases	  share	  with	  CDK9	  similarity	  in	  the	  conformation	  of	  catalytic	  site,	  these	   compound	   show	   activity	   for	   other	   CDKs,	   even	   if	   	   at	   lower	   level	   compare	   to	  CDK9.	  
Flavopiridol	  is	  a	  flavon	  chemically	  synthetized	  from	  an	  alkaloid	  isolated	  from	  leaves	  	  of	  Indian	  plants	  such	  as	  Amoora	  Rohituka	  and	  Dysoxylum	  binectriferum.	  Flavopiridol	  is	   considered	   the	  most	   efficient	   CDK9	   inhibitor.	   It	   binds	   the	  ATP	  binding	   site	   and	  induces	   a	   structural	   change	   in	   the	   kinase.	   This	   compound	   shows	   activity	   also	   for	  CDK1,	  CDK4	  and	  CDK8,	  even	  if	  lower	  affinity.	  In	  leaving	  cells,	  	  Flavopiridol	  efficiently	  inhibits	   CDK9	   in	   the	   range	   of	   100-­‐300	   nM	   (24).	   Moreover,	   it	   is	   a	   water-­‐soluble	  compound	  and	  for	  this	  reason	  very	  useful	  in	  molecular	  biology	  studies.	  
DRB	   (5,6-­‐Dichloro-­‐1-­‐beta-­‐Ribo-­‐furanosyl	   Benzimidazole)	   is	   the	   second	   most	   used	  CDK9	  inhibitors,	  nevertheless	  it’s	  poor	  solubility	  in	  water	  and	  and	  the	  high	  effective	  concentration	  (100	  µM).	  This	  compound	  was	  used	  to	  identify	  the	  role	  of	  P-­‐TEFb	  and	  factor	  DSIF/NELF	   in	  regulating	  PolII	  pausing	  and	  elongation	  (25).	   It	   inhibits	  CDK7	  too,	  with	  a	  3	  fold	  lower	  affinity.	  It’s	  really	  fast	  and	  able	  to	  inhibit	  transcription	  in	  the	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range	   of	   minutes.	   For	   this	   reason	   this	   compound	   can	   be	   used	   to	   measure	  transcription	  rates	  in	  run	  on	  experiments.	  
	  
	  
1.1.4	  Triptolide:	  Effects	  and	  mechanism	  of	  action	  Triptolide	  (TPL)	  has	  recently	  attracted	  the	  attention	  of	  the	  scientific	  community	  due	  to	  its	  many	  interesting	  properties.	  Triptolide	  is	  the	  major	  derivative	  of	  the	  Chinese	  plant	   Trypterygium	   Wilfordi	   Hook	   F.,	   commonly	   used	   in	   traditional	   Chinese	  medicine	   to	   treat	   inflammation	   or	   inflammatory	   diseases	   such	   as	   rheumatoid	  arthritis	  (26).	  It’s	  a	  diterpene	  triepoxide	  (Fig	  2)	  with	  a	  unique	  molecular	  structure,	  showing	   several	   interesting	   pharmacological	   properties:	   anti-­‐inflammation,	  immunomodulation,	  anti-­‐angiogenesis,	  anti	  tumour	  and	  pro-­‐apoptosis.	  	  
	   	  	  	  Pre-­‐clinical	  studies	  show	  that	  Tripolide	  is	  effective	  against	  different	  kinds	  of	  cancer,	  allograft	  rejection,	  and	  arthritis.	  	  Recently,	  it	  has	  entered	  in	  human	  clinical	  trials	  for	  cancer	  treatment.	  	  Triptolide	  was	  first	  investigated	  for	  its	  anti-­‐inflammatory	  activity,	  that	  was	  basically	  explained	  by	  the	  ability	  of	  TPL	  to	  inhibit	  the	  transcriptional	  pathway	  controlled	  by	  NFkB,	   responsible	   for	   regulation	  of	   cytokines	   important	   for	   inflammation,	   as	   IL-­‐2,	  
Fig2.	  Strucure	  of	  Tripolide,.	  Figure	  from	  an	  online	  open	  source.	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1.2	  Top1,	  Camptothecin	  and	  R	  loops	  	  
1.2.1	  DNA	  topology:	  a	  critical	  feature	  for	  cellular	  processes	  	  The	  most	  common	  and	  stable	  DNA	  structure	  is	  B-­‐DNA:	  an	  antiparallel	  double-­‐helical	  structure.	   This	   conformation	   can	   be	   intrinsically	   considered	   as	   a	   double-­‐edged	  sword:	   the	   presence	   of	   two	   strands	  wound	   one	   around	   the	   another,	   on	   one	   side,	  gives	   incredible	  stability	  of	   the	  molecule	  and	  ensures	   that	  genetic	   information	  can	  be	   maintained	   and	   replicated	   correctly;	   but,	   on	   the	   other	   side,	   processes	   that	  require	  strand	  separation,	  such	  as	  replication	  and	  transcription,	   lead	  to	  DNA	  over-­‐winding	   and	   strand	   entanglement	   (34).	   Additionally,	   at	   intracellular	   level,	   DNA	   is	  not	   a	   free	   and	   relaxed	   molecule.	   First	   of	   all,	   DNA	   is	   associated	   to	   proteins	   like	  histones	   to	   form	  nucleosomes,	  while	   several	   other	  proteins	   (transcription	   factors,	  polymerases…etc)	  contribute	   to	  constitute	  a	  well-­‐structured	  DNA-­‐protein	  complex	  called	  chromatin.	  Chromatin	  is	  organized	  in	  structured	  levels;	  each	  of	  them	  is	  well	  defined,	   relatively	   stable	   and	   highly	   regulated.	   Chromatin	   state	   can	   change	  according	   to	   the	   cellular	   phase	   or	   cellular	   regulation:	   modulating	   chromatin	  packaging	   regulates	   accessibility	   of	   DNA	   therefore	   affecting	   also	   transcriptional	  response	   and	   gene	   expression.	  Third,	  DNA	   is	   also	   anchored	   to	  nuclear	  membrane	  and	   this	   interaction	   is	   essential	   in	   maintaining	   nuclear	   structure.	   On	   the	   basis	   of	  these	  considerations,	  we	  know	  that	  DNA	  is	  not	  a	  free	  and	  relaxed	  molecule;	  instead	  it	  is	  highly	  constrained	  by	  several	  interactions.	  In	  the	  presence	  of	  these	  constraints	  cellular	  processes	  like	  replication,	  transcription,	  chromosomal	  segregation	  and	  chromatin	  remodeling	  create	  a	  torsional	  stress	  on	  the	  DNA	   molecule	   leading	   the	   DNA	   double	   helix	   to	   coil	   around	   it	   self,	   generating	   a	  
supercoil.	  According	  to	  DNA	  helix	  directionality	  and	  the	  type	  of	  torsional	  stress	  created,	  a	  DNA	  molecule	  can	  be	  over-­‐wound,	  (or	  positively	  super-­‐coiled)	  or	  under-­‐wound	  (negative	  
supercoiling)	  (35).	  With	  the	  exception	  of	   few	  hyperthermophilus	  organisms,	   for	  all	  the	  other	  organisms	  the	  genomic	  DNA	  is	  slightly	  negatively	  supercoiled	  on	  average.	  A	   negative	   supercoiled	   DNA	   tends	   to	   melt	   easily,	   therefore	   facilitating	   cellular	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processes	   that	   need	   the	   DNA	   to	   be	   open	   and	   in	   a	   single	   strand	   form	   (such	   as	  replication	   and	   transcription).	   Instead,	   a	   positively	   supercoiling	   hinders	   these	  processes,	  slowing	  down	  their	  progression	  and	  making	  DNA	  more	  difficult	  to	  melt.	  For	   example,	   using	   an	   in	   vitro	   system,	   it	   has	   been	   shown	   that	   DNA	   replication	  machinery	  can	  replicate	  only	  on	  negatively	  supercoiled	  DNA.	  The	  DNA	  polymerase	  stalls	   before	   replication	   is	   complete,	   and	   this	   is	   probably	   caused	   by	   the	  accumulation	   of	   positive	   supercoilings	   in	   front	   of	   the	   replication	   machinery.	  	  Importantly,	   the	  replication	  can	  be	  restored	  upon	   the	  addition	  of	  a	   topoisomerase	  able	  to	  remove	  positive	  supercoiling	  (36).	  On	   the	  other	  side,	  also	  negative	  supercoil	  can	  be	  dangerous	   for	  cell,	  and	   therefore	  they	   have	   to	   be	   highly	   regulated.	   As	   told	   previously,	   a	   negative	   supercoiled	   DNA	  tends	  to	  melt	  easily,	  this	  can	  favor	  the	  re-­‐annealing	  of	  the	  RNA	  molecule	  during	  the	  transcription	   phase	   leading	   to	   the	   formation	   of	   an	   R	   loop,	   a	   structure	   that	   is	  frequently	  cause	  of	  genomic	  instability	  (37).	  This	  means	  that	  DNA	  topology	  can	  have	  great	   influence	  in	  cellular	  process	  and	  has	  to	  be	  therefore	  highly	  regulated.	  This	   is	  why	   both	   prokaryotic	   and	   eukaryotic	   organisms	   have	   developed	   several	  mechanisms	   and	   conserved	   several	   enzymes	   to	   overcome	   topological	   problems.	  Particularly,	  to	  bypass	  problems	  generated	  by	  the	  presence	  of	  supercoils,	  knots	  and	  interwound,	  one	  of	  the	  DNA	  molecule	  has	  to	  be	  cleaved	  allowing	  a	  strand	  rotation	  that	   relaxes	   the	   double	   helix	   removing	   supercoils.	   Enzymes	   able	   to	   catalyze	   such	  reactions	  are	  essential	  for	  the	  cell	  life.	  Moreover	  by	  introducing	  transient	  nick	  in	  the	  DNA	   molecule,	   these	   enzymes	   are	   potentially	   deleterious	   and	   have	   to	   be	   finely	  regulated.	  The	  enzymes	  able	  to	  modify	  DNA	  topology	  are	  named	  topoisomerases.	  	  	  
1.2.2	  DNA	  topoisomerases	  DNA	  topoisomerases	  are	  enzymes	  able	  to	  remove	  or	  introduce	  positive	  and	  negative	  supercoilings	  in	  the	  DNA	  molecule,	  to	  catenate/decatanate	  two	  molecules	  of	  DNA	  or	  to	   knot/unknot	   DNA.	   To	   perform	   these	   tasks,	   DNA	   topoisomerases	   have	   to	  introduce	  one	  or	  two	  breaks	  on	  DNA	  and	  pass	  one	  strand	  of	  the	  DNA	  throughout	  a	  break	   in	   the	  other	   strand	  or	  pass	   a	   region	  of	   the	  DNA	  duplex	   from	   the	   same	  or	   a	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different	  molecule	   throughout	   a	   double-­‐strand	   break	   (DSB).	   In	   this	   reaction	   DNA	  cleavage	  is	  en	  essential	  step,	  usually	  accomplished	  by	  forming	  a	  transient	  phosphor-­‐tyrosine	  bond	  between	  the	  tyrosine	  of	   the	  enzyme	  active	  site	  and	  a	  3’	  or	  5’	  end	  of	  the	  DNA	  molecule.	  During	  this	  catalysis	  the	  enzyme	  modifies	  the	  DNA	  topology	  and	  subsequently	  religate	  and	  release	  DNA.	  	  	  In	   nature	   there	   are	   four	   classes	   of	  DNA	   topoisomerases,	  with	   different	   properties	  and	  structures.	  We	  can	  mainly	  distinguish	  topoisomerases	  in	  two	  groups:	  Type	  I	  and	  II.	  
• Type	   I	   Topoisomerases	   cleave	   one	   DNA	   strand	   only.	   This	   category	   can	  additionally	   be	   split	   in	   two	   subfamilies:	   type	   IA	   topoisomerases	   form	  transient	   phosphor-­‐tyrosin	   bond	   with	   the	   5’	   phosphates	   of	   DNA	   ends,	  whereas	   type	   IB	   topoisomerases	   do	   with	   3’	   phosphate.	   Type	   IA	   subfamily	  includes:	   bacterial	   topoisomerase	   I	   and	   III,	   archeal	   reverse	   gyrase,	   and	  eukaryotic	   topoisomerase	   III.	   These	   enzymes	   have	   preference	   for	   relaxing	  highly	  negative	  supercoiled	  DNA	  molecules.	  (38).	  Reverse	  gyrase	  has	  unique	  properties	   and	   it’s	   the	   only	   enzyme	   able	   to	   introduce	   positive	   supercoils	  (39).	   Typ1	   IB	   subfamily	   includes	   eukaryotic	   Topoisomerase	   I,	   poxvirus	  topoisomerase	  I	  and	  some	  homologous	  in	  bacteria.	  (40)	  
• Type	   II	   topoisomerase	   cleave	   both	   strands	   of	   a	   double	   helix	   generating	   a	  double	  strand	  break.	  Also	  this	  category	  can	  be	  divided	  in	  two	  subfamilies	  on	  the	  basis	  of	   their	  aminoacidic	   sequence	  and	  structure:	   IIA	  and	   IIB.	  Type	  IIA	  
topoisomerases	   are	   really	   common	   in	   nature,	   while	   Type	   IIB	   seem	   to	   be	  exclusive	   of	   Archea	   and	   Plants.	   Type	   IIA	   subfamiliy	   includes:	   eukaryotic	  topoisomerase	   II	   (TOP	   2),	   bacterial	   DNA	   gyrase	   and	   topoisomerase	   IV,	  prokaryotic	   topoisomerase	   II.	  These	  enzymes	  can	  resolve	  both	  positive	  and	  negative	  supercoils,	  and,	  additionally,	  they	  can	  decatenate	  and	  unknot	  DNA.	  Both	  type	  II	  topoisomerase	  categories	  are	  multisubunit	  enzymes,	  and	  have	  a	  similar	  mechanism	  of	  action:	  double	  strand	  breaks	  performed	  by	  the	  enzyme	  covalently	   linked	   to	   5‘	   ends	   of	   DNA.	   Topoisomerase	   II	   usually	   catalyzes	  topological	   modifications	   by	   passing	   a	   second	   DNA	   duplex	   through	   the	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cleavage	  of	  another	  DNA	  segment.	  This	  mechanism	  requires	  ATP	  and	  Mg2+.	  (40)	  Taken	  together,	  all	  topoisomerases	  can	  resolve	  any	  topological	  problem	  created	  by	  main	  cellular	  processes:	  1) Replication	   and	   Segregation	   of	   newly	   replicated	   chromosome:	   during	   the	  replication	   process,	   an	   ongoing	   replication	   fork	   usually	   generates	   positive	  supercoils	   ahead	   of	   itself,	   on	   the	   unreplicated	   DNA	   molecule.	   These	  supercoils	  can	  hinder	  replication.	   If	   the	  replication	  machinery	   is	  allowed	  to	  rotate	  these	  positive	  supercoils	  can	  partially	  dissipate,	  but	  as	  a	  consequence	  of	   the	   fork	   rotation,	   duplicated	   DNA	   molecule	   will	   intertwine.	   As	   regards	  positive	  supercoils,	  these	  topological	  problems	  can	  be	  resolved	  by	  a	  Type	  IB	  or	  II,	  but	  for	  the	  intertwined	  duplicated	  molecules,	  a	  Type	  II	  topoisomerase	  is	  essential	   (41)	   At	   the	   end	   of	   replication	   step,	   two	   replication	   forks	   usually	  collide	  and	  the	  problem	  of	  decatenating	  the	  new	  synthetized	  DNA	  molecules	  arises.	   Type	   IB	   topoisomerase	   cannot	   accomplish	   to	   this	   task.	   Therefore,	   a	  type	   II	   topoisomerase	   activity	   is	   required.	   In	   general,	   in	   eukaryotes	   Top	   II	  seems	  critical	  for	  chromosomal	  decatenation	  (41).	  2) Transcription:	  according	   to	   the	   supercoiled	   twin-­‐domain	  model	   (42),	   during	  transcription	  an	  RNA	  Polymerase	  translocate	  along	  DNA	  generating	  positive	  supercoils	  ahead	  and	  negative	  supercoils	  behind	  it.	  Both	  kinds	  of	  superocoils	  have	   to	   be	   removed	   for	   a	   correct	   progression	   of	   elongation.	   Positive	  supercoils	   represent	   a	   physical	   barrier	   to	   the	   progression	   of	   RNA	  Polymerase,	  while	  negative	   supercoils	   can	   favor	  R	   loop	   formation	   that	   also	  affects	  polymerase	  elongation.	  Type	  I	  B	  topoisomerases	  are	  the	  major	  class	  of	  topoisomerase	  associated	  with	  transcription.	  	  However,	  yeast	  strains	  deleted	  for	  Top1	  do	  not	  have	  an	   impaired	  transcription	  process,	  which	  only	  appear	  in	  the	  presence	  of	  double	  Top1	  and	  Top2	  deletions	  (43)	  3) DNA	  Recombination:	  In	   this	  process	  a	  Type	   IA	   topoisomerase	  seems	  to	  play	  an	  essential	  role	  and	  this	  is	  probably	  why	  all	  the	  organisms	  possess	  at	  least	  one	  Type	  IA	  topoisomerase.	  Both	  in	  bacteria	  and	  yeast	  it	  has	  been	  shown	  that	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removal	  of	  this	  kinds	  of	  topoisomerase	  increase	  genomic	  instability	  mediated	  by	  proteins	  involved	  in	  recombination	  (44)	  	  4) Chromosomal	   condensation	   and	   structure:	   topoisomerases	   can	   be	   also	  involved	   in	   these	   two	  processes.	   Chromosomal	   condensation	  may	   generate	  torsional	   stress	   that	   has	   to	   be	   dissipated.	   Additionally	   chromosomal	  decatenation	  and	  condensation	  are	  strictly	  linked.	  Therefore,	  topoisomerase	  II	  have	  been	  found	  to	  be	  essential	  for	  these	  processes.	  Moreover	  it	  has	  been	  shown	   that	   topoisomerase	   II	   are	   part	   of	   a	   scaffold	   that	   constitute	   mitotic	  chromosomes.	  
	  
1.2.3	  Human	  DNA	  Topoisomerase	  I:	  structure	  and	  mechanism	  of	  	  	  
	  	  	  	  	  	  	  	  	  	  action	  The	   human	   DNA	   Topoisomerase	   I	   (Top1)	   is	   probably	   the	   most	   studied	   and	   well	  characterized	   type	   IB	   topoisomerase.	   It’s	   a	   protein	   of	   about	   91	   kDa	   basically	  composed	   of	   4	   domains	   (Fig	   3).	   The	   N-­‐terminal	   domain	   has	   four	   NLS,	   nuclear	  localization	   signals.	   This	   domain	   is	   not	   important	   for	   the	   catalytic	   activity	   of	   the	  enzyme;	  it	  is	  the	  site	  of	  interaction	  with	  several	  other	  proteins	  (40)	  and	  it	  is	  poorly	  conserved.	   Following	   the	   N-­‐term	   domain	   we	   can	   find	   the	   core	   domain,	   highly	  conserved,	   really	   important	   for	   the	   interaction	   that	   Top1	   realized	   with	   DNA.	   It	  includes	   all	   the	   residues	   that	   compose	   the	   active	   site,	   with	   the	   exception	   of	   the	  tyrosine	  catalytic	  residue	  	  (Tyr273)	  (40).	  This	  latter	  is	  instead	  part	  of	  the	  C	  terminal	  
domain.	  A	  linker,	  dispensable	  and	  poorly	  conserved,	  connects	  core	  domain	  and	  C	  	  
	  ter Fig3.	  Domain	  structure	  of	  human	  DNA	  Topoisomerase	  I.	  Fig	  from	  Champoux,	  J.J.,	  DNA	  topoisomerases:	  structure,	  function,	  and	  mechanism.	  Annu.	  Rev.	  Biochem.,	  (2001).	  70:	  p.	  369–413	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m	  domain.	  As	  regards	  the	  mechanism	  of	  action	  the	  enzyme	  act	  as	  a	  clamp	  that	  allocates	  DNA	  in	  the	  middle.	  The	  core	  domain	  can	  be	  theoretically	  divided	  in	  three	  sub-­‐domains	  (I,	  II,	  III).	  Sub-­‐domain	  I	  and	  II	  form	  one	  side	  of	  the	  clamp	  (called	  cap),	  while	  the	  other	  part	  of	   the	   clamp	   is	   basically	   composed	   by	   sub-­‐domain	   III	   and	   C	   term	   domain.	   Such	  structure	   seems	   to	   give	   to	   Top1	   higher	   affinity	   to	   supercoiled	   DNA	   compare	   to	  relaxed	   DNA	   (45).	   The	   mechanism	   of	   action	   of	   Top1	   is	   as	   simple	   as	   effective:	   a	  nucleophilic	  attack	  of	  an	  oxygen	  of	  Tyr273	  is	  realized	  on	  the	  scissile	  phosphate.	  This	  creates	  a	  phosphodiesteric	  bond	  between	  Tyr273	  and	  a	  3‘	  phosphate,	  leaving	  a	  5’OH	  free.	  At	  this	  step	  Top1	  is	  covalently	  linked	  to	  one	  strand	  of	  DNA	  and	  can	  therefore	  allow	   the	   rotation	   of	   this	   strand	   around	   the	   other	   to	   remove	   supercoil.	   This	   is	  performed	  using	  the	  intrinsic	  free	  energy	  of	  the	  DNA	  molecule	  and	  this	  is	  why	  Top1	  does	  not	  necessitate	  of	  ATP.	  The	  strand	  rotation	  catalyzed	  by	  Top1	  is	  considered	  a	  “controlled	   rotation”,	   since	   some	   interactions	   of	   the	   linker	   and	   the	   core	   domain	  slowed	  down	  this	  rotation	  (46)	  (Fig	  5).	  The	  relegation	  step	  needs	  that	  the	  5’	  OH	  is	  realigned	   with	   Tyr273.	   In	   normal	   condition	   this	   reaction	   is	   thermodynamically	  favored	  and	  this	  is	  why	  the	  cleavage	  intermediates	  are	  transient	  and	  really	  fast.	  	  	  
	  
	  
Fig	  4.Two	  views	  of	  structure	  of	  human	  DNA	  Top1	  in	  the	  presence	  of	  DNA.	  A)View from the side with the DNA axis 
horizontally oriented and B) View looking down the axis of the DNA.	   Figure	   from	   Champoux,	   J.J.,	   DNA	  
topoisomerases:	  structure,	  function,	  and	  mechanism.	  Annu.	  Rev.	  Biochem.,	  (2001).	  70:	  p.	  369–413	  









Fig5.	  Role	   and	  Mechanism	   of	   action	   of	   DNA	   Top1. A) Torsianl stress created by physiological processes such as DNA 
replication, transcription and chromatin remodelling. b ) The introduction of DNA single-strand breaks (nicks) by TOP1 
provides allowe the rotation	  of	  the	  intact	  DNA	  strand	  around	  the	  break	  and	  facilitate	  DNA	  relaxation.	  	  c)	  An	  expanded	  view	  of	  DNA	  
relaxation	  by	  a	  TOP1	  cleavage	  complex	  (TOP1cc).	  Figure	  from	  Pommier,	  Y.,	  Topoisomerase	  I	  inhibitors:	  camptothecins	  and	  beyond.	  
Nat.	  Rev.	  Cancer,	  (2006).	  6(10):	  p.	  789-­‐802.	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1.2.5	  Inhibition	  of	  Top1	  by	  Camptothecin:	  mechanism	  of	  action	  and	  	  	  	  
	  	  	  	  	  	  	  	  	  	  molecular	  	  effects	  Top1	   can	   be	   targeted	   and	   specifically	   inhibited	   by	   Camptothecin	   (CPT).	   This	  compound	   is	   extracted	   from	   the	   Chinese	   plant	   Camptotheca	   acuminata	   and	   was	  known	   for	   its	   antitumor	   activity	   before	   the	   	   identification	   of	   Top1	   as	   its	   specific	  target	  (47).	  CPT	   and	   its	   derivatives	   (irinotecan,	   topotecan)	   (Fig	   6)	   are	   able	   to	   interfere	   with	  cleavage/ligation	  reaction	  catalyzed	  by	  Top1.	  This	  reaction	  is	  usually	  really	  fast	  and	  undetectable	   at	   physiological	   level.	   In	   the	   presence	   of	   CPT	   the	   half-­‐life	   of	   the	  cleavage	  intermediate,	  defined	  as	  Top1	  cleavage	  complex	  	  (Top1cc),	  is	  prolonged	  and	  	  	  
	  
	  Fig	  6.	  Camptothecin	  and	  derivatives.	  Figure	  from	  Pommier,	  Y.,	  Topoisomerase	  I	  inhibitors:	  camptothecins	  and	  beyond.	  Nat.	  Rev.	  Cancer,	  (2006).	  6(10):	  p.	  789-­‐802.	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  the	   Top1cc	   results	   stabilized.	   	   This	   kind	   of	   inhibition	   is	   specific	   for	   Top1	   and	  reversible.	  As	  CPT	  can	  entrap	  Top1	  on	  DNA	  in	  a	  reversible	  manner,	  this	  drug	  and	  its	  derivatives	  are	  considered	  Top1	  poisons.	  The	  mechanism	  of	  action	  of	  CPT	  has	  been	  deeply	   investigated,	   although	   not	   fully	   understood.	   First,	   CPT	   is	   active	   on	   Top1	  bound	   to	   DNA	   and	   not	   on	   the	   free	   protein,	   demonstrating	   that	   it	   is	   a	   non-­‐competitive	   inhibitor	   of	   Top1.	   It	   is	   thought	   that	   CPT	   is	   able	   to	   intercalate	   in	   the	  pocket	  formed	  between	  Top1	  and	  DNA,	  at	  level	  of	  the	  cut	  strand	  and	  could	  induce	  a	  misalignment	  of	  the	  5’OH	  free	  end	  that	  has	  to	  attack	  the	  phospho-­‐tyrosine	  bond	  to	  complete	   the	   religation	   step	   (47)	   (53)	  Top1-­‐cc	  are	   strongly	   stabilized	  by	  CPT,	  but	  they	   can	   be	   present	   also	   at	   physiological	   levels	   in	   the	   presence	   of	   DNA	   adducts,	  mismatches,	  pre-­‐existing	  lesions	  and	  ribonucleotides	  in	  the	  template	  (47).	  The	  antitumor	  effects	  of	  CPT	  can	  be	  explained	  with	  the	  ability	  of	  this	  drug	  to	  induce	  DNA	  damage.	  Anyway	  since	  Top1cc	  stabilized	  by	  CPT	  is	  transient	  and	  reversible,	  it	  is	  not	  the	  drug	  itself	  that	  introduce	  a	  lethal	  damage	  of	  the	  genome.	  It	  is	  instead	  the	  Top1cc	  that	  induces	  a	  DNA	  damage	  by	  interfering	  with	  processes	  such	  as	  replication	  and	  transcription.	  Campthotecin	  specifically	  kills	  cells	  in	  S-­‐phase	  as	  Top1cc	  colliding	  with	   an	   ongoing	   replication	   fork	   triggers	   the	   formation	  of	   a	  DSB	  on	   the	   template.	  The	  DSB	   is	   the	   lethal	  event	   that	  eventually	   leads	   to	  genome	   instability	  and/or	  cell	  death	  (54)	  (Fig	  7	  a).	  The	   cellular	   consequences	   of	   this	   event	   are	   an	   S-­‐phase	   specific	   cell	   killing	   and	   an	  arrest	  at	  G2	  phase.	  This	  is	  obviously	  regulated	  by	  a	  molecular	  cascade	  triggered	  by	  the	  replication-­‐induced	  double	  strand	  breaks:	  activation	  of	  checkpoint	  kinases	  ATM,	  ATR	   and	   DNA	   PK.	   These	   key	   regulators	   of	   the	   cellular	   cycle	   checkpoint	  phosphorylate,	  among	  their	  several	  targets,	  CHK2	  and	  CHK1	  and	  the	  marker	  of	  DBS	  DNA	   damage	   g-­‐H2AX.	   This	   cascade	   continues	   with	   CDC25	   phosphates	   inhibition,	  p53	  activation	  and	  cell	  cycle	  arrest	  (47).	  Considering	   the	   important	   role	   that	   Top1	   has	   in	   transcription	   it	   is	   not	   surprising	  that	  CPT	  has	  great	  influence	  on	  this	  process.	  Synthesis	  of	  the	  45S	  precursor	  rRNA	  is	  impaired	  during	  CPT	  treatment	  (55).	  Transcriptional	  inhibition	  by	  CPT	  seems	  to	  be	  an	   early	   effect	   of	   the	   drug,	   and	   involves	   both	   Pol	   I	   and	   Pol	   II	   mediated	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transcriptions.	   For	   both	   kinds	   of	   transcriptions,	   camptothecin	   seems	   to	   affect	   the	  elongation	   phase	   (55),	   (56).	   Interestingly,	   Top1	   inhibition	   by	   CPT	   has	   important	  effects	  on	  RNA	  Polymerase	  II.	  During	  CPT	  treatments	  PolII	   is	  hyperphosphorilated	  at	   ser5	   of	   CTD	   and	   this	   phosphorylation	   is	   mediated	   by	   CDK7.	   Interestingly	   this	  hyperphosphorylation	  does	  not	  impair	  PolII	  stability	  (57).	  
	  	  Fig	   7.	   Interference	   of	   Top1	   cc	   with	   a)Replication	   and	   B)	   Transcription.	   Figure	   from	   Pommier,	   Y.,	  
Topoisomerase	  I	  inhibitors:	  camptothecins	  and	  beyond.	  Nat.	  Rev.	  Cancer,	  (2006).	  6(10):	  p.	  789-­‐802.	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Collision	   of	   a	   transcribing	   RNA	   polymerase	   II	   on	   a	   Top1cc	   can	   make	   this	  intermediate	   irreversible	   (Fig	   7	   b).	   How	   much	   is	   the	   contribution	   of	   this	  phenomenon	  to	  DNA	  damage,	  genomic	  instability	  and	  therefore	  drug	  cytotoxicity	  in	  replicating	   cells	   is	   not	  well	   understood.	   Inteserestingly,	   cells	   defective	   in	   TC-­‐NER	  	  (transcription	  coupled–nucleotide	  excision	  repair)	  are	  hypersensitive	  to	  CPT.	  (58)	  One	   molecular	   mechanism,	   strictly	   related	   to	   transcription,	   is	   the	   degradation	   of	  Top1	  during	   camptothecin	   treatment.	  Once	   that	  Top1	   is	   entrapped	   to	  DNA	  within	  few	  minutes	  of	  CPT	  treatment,	  it	  is	  modified	  trough	  ubiquitination	  and	  sumoylation	  and	  degraded	  via	  26s	  Proteasome	  (59).	  The	  ability	  to	  degrade	  Top1	  in	  the	  presence	  of	   CPT	   correlates	   with	   the	   cell	   line	   resistance	   to	   the	   drug.	   Interestingly,	   this	  ubiquitination	  is	  strictly	  dependent	  to	  transcription	  (60)	  and	  performed	  by	  several	  such	  as	  the	  tumor	  suppressor	  BRCA1	  (58).	  However	  the	  transcriptional	  effects	  of	  CPT	  are	  not	  confined	  to	  the	  above-­‐mentioned.	  Some	   of	   the	   transcriptional	   effects	   of	   CPT	   are	   really	   fascinating	   and	   not	   fully	  understood.	   Top1	   can	   act	   as	   a	   kinase	   and	   phosphorylate	   splicing	   related-­‐factors	  (61).	   So	  by	   inhibiting	  Top1,	  CPT	   can	   impair	   splicing.	   (62)	  However,	   it	   is	   not	   clear	  how	  Top1	  can	  act	  as	  kinase,	  as	  it	  does	  not	  have	  a	  kinase	  domain.	  One	  possibility	  is	  that	  the	  impaired	  phosphorylation	  of	  SR	  proteins	  is	  an	  indirect	  consequence	  of	  Top1	  inhibition	  by	  CPT.	  The	   unbalancing	   of	   phosphorylation	   of	   PoII	   during	   CPT	   treatment	   (57)	   can	   alter	  POlII	   distribution	   along	   transcribe	   genes.	   Recently,	   our	   group	   demonstrated	   that	  Top1	  inhibition	  by	  CPT	  increases	  escape	  of	  PolII	   from	  pausing	  sites,	  via	  CDKs,	  and	  induces	   antisense	   transcription	   at	   the	   HIF1a	   locus	   (63).	   If	   this	   phenomenon	   is	  exclusive	  of	  HIF1a	  or	  if	  Top1	  regulates	  genome	  wide	  antisense	  transcription	  is	  not	  clear.	  A	  very	  recent	  paper	  brought	  to	  light	  new	  properties	  of	  CPT	  and	  topoisomerase	  inhibitors.	  In	  a	  screening	  for	  drugs	  in	  an	  Angelman	  disease	  mouse	  model,	  Top1	  and	  Top2	   inhibitors	   were	   found	   to	   be	   the	   only	   compounds	   able	   to	   unsilence	   the	  imprinted	  gene	  Ube3a,	  responsible	  for	  Angelman	  disease.	  These	  novel	  insights	  give	  new	  light	  to	  topoisomerase	  inhibitors	  as	  potential	  therapeuticals	  	  for	  the	  	  treatment	  of	  this	  neurological	  disorder.	  Interestingly,	  CPT	  and	  derivatives	  induce	  a	  decrease	  of	  the	  antisense	  present	  at	  the	  imprinted	  locus.	  (64)	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All	   these	   data	   revealed	   that	   Top1	   can	   be	   a	   key	   regulator	   of	   transcription	   and	  transcription-­‐related	  process.	  So	  the	  investigation	  of	  this	  enzyme	  and	  the	  use	  of	  its	  specific	   inhibitor	   CPT	   can	   bring	   novel	   insights	   in	   the	   field	   of	   regulation	   of	  transcription	  	  
1.2.6	  Top1	  and	  R	  Loops	  Another	   possible	   mechanism	   of	   DNA	   damage	   induced	   by	   camptothecin	   is	   the	  formation	  of	  R	   loops.	  An	  R	   loop	   is	   three	  stranded	  nucleic	  acid	  structure	  composed	  by	   a	   DNA/RNA	   hybrid	   and	   a	   single	   strand	   DNA.	   R	   loops	   are	   usually	   form	   co-­‐transcriptionally	   when	   the	   nascent	   transcript	   is	   able	   to	   re-­‐anneal	   to	   the	   DNA	  template	   and	   leave	   the	   non-­‐template	   DNA	   in	   single	   strand	   form	   (65).	   These	  structures	  have	  been	  always	  considered	  “dangerous”	  since	  can	  represent	  a	  source	  of	  genome	   stability.	   Three	   features	   can	   favor	   R	   loop	   formation:	   1)	   an	   asymmetry	   in	  guanine	   distribution	   such	   that	   the	   nascent	   RNA	   result	   G	   rich	   (GC	   skew)	   2)	   the	  presence	  of	  a	  nick	  on	  the	  non-­‐template	  DNA	  3)	  the	  presence	  of	  negative	  supercoils.	  (66).	  Particularly,	  as	  regards	   the	   topology,	   the	  presence	  of	  negative	  supercoils	  can	  lead	  to	   the	  separation	  of	   the	  two	  strands	  thus	   favoring	  the	  RNA	  invasion.	  So	  Top1	  and	  R	  loops	  are	  clearly	  interconnected.	  	  First	  evidence	  of	  a	  possible	  role	  of	  Top1	  in	  R	  loops	  homeostasis	  came	  with	  Drolet’s	  studies	  in	  E.	  coli:	  topA	  mutants	  complemented	  growth	  defects	  by	  overexpression	  of	  RNAseH,	   enzyme	  able	   to	   specifically	  degrade	  RNA/DNA	   hybrids	   (67),	   (68).	   In	   S.	   cerevisiae	   R	   loops	   form	   at	   rDNA	   loci	   in	  Top1Δ	  Top2Δ	   strains	   and	   are	   enhanced	   by	   co-­‐depletion	   of	   RNAseH1	   (69).	   	   In	  mammals	   it	   has	   been	   shown	   that	   Top1	   depletion	   induces	   interference	   between	  replication	  and	  transcription	  and	  this	  effect	  is	  reversed	  by	  RNAseH1	  overexpression	  (70).	   Obviously,	   also	   CPT	   can	   have	   a	   role	   in	   stabilizing	   R	   loops.	   Sordet	   et	   al.	  demonstrated	  that	  CPT	  is	  able	  to	  induced	  DSB	  and	  DDR	  response	  via	  ATM,	  in	  non-­‐replicating	  cells	  such	  as	  neurons	  and	  lymphocytes.	  	  Interestingly,	  this	  DNA	  damage	  is	  partially	  reversed	  in	  the	  presence	  of	  an	  overexpression	  of	  RNAseH1	  (71).	  	  R	  loops	  can	  also	  play	  a	  role	  in	  the	  reactivation	  of	  the	  paternal	  Ube3a	  allele	  by	  CPT,	  as	  it	  has	  been	   found	   that	  CPT	  stabilize	  an	  R	   loop	   in	   this	   imprinted	   locus,	  which	  maintain	  a	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decondensed	   chromatin	   state,	   allowing	   transcription	   of	   the	   paternal	   Ube3a	   allele	  (72).	  Top1	  is	  not	  the	  only	  topoisomerase	  involved	  in	  preventing	  R	  loops.	  A	  really	  recent	  paper	  showed	  that	  TOP3b	  is	  recruited	  to	  chromatin	  to	  prevent	  R	  loop	  formation,	  by	  interacting	  with	  TDRD3	  that	  recognizes	  di-­‐methylated	  arginine	  in	  histone	  H4	  (73).	  However,	  considering	  the	  marginal	  role	  of	  TOP3b	  in	  transcription,	  restricted	  to	  few	  loci,	   the	  main	   topological	   regulator	   that	   can	  affect	  R	   loop	   stability	   remains,	   in	  our	  knowledge,	  Top1.	  All	  the	  previously	  described	  studies	  assessed	  a	  role	  of	  R	  loops	  in	  Top1-­‐driven	   genomic	   instability	   by	   indirect	   evidence	   (usually	   an	  overexpression/deletion	  of	  RNAseH).	   	  However,	  direct	  proofs	   that	  Top1	  depletion	  or	   inhibition	   by	   CPT	   stabilize	   R	   loops	   are	   still	  missing.	  Moreover,	   a	   genome	  wide	  mapping	  of	  these	  structure	  in	  the	  presence/absence	  of	  Top1,	  or	  in	  the	  presence	  of	  CPT	  was	  not	  performed	  yet.	  	  
1.2.7	  R	  loops	  and	  genomic	  instability	  R	  loop	  formation	  can	  be	  considered	  a	  dangerous	  process.	  Leaving	  the	  non	  template	  DNA	  in	  a	  single	  strand	  form	  because	  of	  DNA/RNA	  hybridization,	  can	  be	  a	  source	  	  of	  DNA	  damage.	  Anyway	  how	  R	  loop	  can	  cause	  genome	  instability	  is	  not	  clear	  yet.	  The	  ssDNA	   can	   be	   a	   template	   for	   process	   such	   transcription-­‐associated	   mutagenesis	  (TAM)	   and	   transcription-­‐associated	   recombination	   (TAR).	   First,	   the	   single	   strand	  DNA	  can	  undergo	  to	  spontaneous	  deamination	  of	  dC	  to	  dU	  therefore	  inserting	  point	  mutations	  (74).	  Another	  possibility	  is	  that	  specific	  proteins	  can	  recognize	  the	  ssDNA	  or	  the	  entire	  R	  loops	  and	  triggers	  the	  mutagenesis	  process.	  One	  possible	  candidate	  to	  this	  is	  the	  activation-­‐induced	  cytidine	  deaminase	  AID	  for	  example,	  involved	  in	  Ig	  heavy	   chain	   CSR	   and	   hypermutation	   in	   B-­‐lymphocytes.	   This	   enzyme	   deaminates	  cytosines	  in	  uracyle	  on	  ss	  DNA	  (75).	  However	  AID	  expression	  seems	  to	  be	  restricted	  to	  lymphocites	  and	  cannot	  explain	  alone	  the	  mutagenic	  pattern	  induced	  by	  R	  loops	  in	  every	  kind	  of	  cell.	  Another	  potential	  source	  of	  genomic	  instability	  triggered	  by	  R	  loops	   can	   be	   the	   interference	  with	   replication	   (76).	   Collision	   between	   replication	  fork	  and	  a	  stalled	  PolII,	  can	  trigger	  TAR,	  although	  the	  exact	  mechanism	  is	  not	  clear.	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A	  replication	  fork	  (RF)	  can	  collide	  with	  the	  R	  loop	  itself	  or	  alternatively	  R	  loop	  can	  induce	  stalling	  an	  RNA	  polymerase	  that	  will	  crush	  with	  the	  RF.	  Anyway	  what	  make	  a	  break	  (single	  or	  double	  strand)	  on	  the	  DNA	  molecule	   in	   the	  presence	  of	  an	  R	   loop	  still	  remains	  mainly	  unclear.	  Apart	  the	  above-­‐mentioned	  Topoisomerase,	  what	  other	  factor	  can	  prevent	  R	  loop	  formation?	  	  The	  first	  factors	  that	  have	  to	  be	  cited	  are	  obviously	  RNAseH	  enzymes.	  These	  enzyme	  are	  able	  to	  specifically	  cleave	  the	  RNA	  moiety	  in	  an	  RNA/DNA	  duplex.	  Most	  part	  of	  organisms	  have	  two	  classes	  of	  RNAse	  H,	  type	  1	  and	  type2,	  the	  first	  monomeric,	  the	  second	  multimeric.	   RNAseH1	   is	   present	   both	   in	   nucleus	   and	  mitochondria.	   In	   the	  first	  compartment	  RNAseH1	  seems	  to	  degrade	  R	  loops	  associated	  with	  transcription	  (77),	   while	   at	   mitochondria	   level	   it	   seems	   to	   play	   a	   role	   in	   replication	   of	   the	  mitochondrial	   DNA	   (78).	   	   Differently	   from	   RNAseH1,	   RNAseH2,	   can	   cleave	   also	   a	  single	   ribonucleotide	  misuncorporated	   in	   the	  DNA	  molecule.	   It	   is	   also	   responsible	  for	   removal	   of	   the	   Okazaki	   primer	   composing	   the	   RNA	   primer	   on	   the	   replicating	  lagging	   strand	   (79).	   Notably	   RHAseH2	   is	   mutated	   	   in	   a	   severe	   immunological	  disorder	  called	  Acardi-­‐Goutieres	  Syndrome.	  Another	   important	   class	   of	   proteins	   able	   to	   remove	   R	   loops	   are	   the	   DNA/RNA	  
helicases:	  in	  yeast	  Pif1,	   in	  mammals	  DXH9	  and	  Senataxin,	  among	  them	  the	   latter	   is	  definitively	  better	  studied.	  Senataxin	  (Sen1	  in	  yeast),	  in	  particular,	  is	  mutated	  in	  two	  severe	  neurological	  diseases:	  ataxia	  oculomotor	  apraxia	  2	   (AOA2)	  and	  amyotrophic	  
lateral	  sclerosis	  type	  4	  (ALS4).	  Senataxin	  has	  been	  shown	  to	  protect	  replication	  fork	  along	  RNA	  Polymerase	  II	  transcribed	  genes	  by	  impeding	  formation	  of	  R	  loops	  (80)	  Another	  important	  process	  that,	  if	  altered,	  can	  affect	  R	  loops	  formation	  is	  the	  mRNA	  
packaging	  and	  RNA	  export	   pathway.	   In	  mammals	   these	   two	   processes	   are	   strictly	  linked	   and	   accomplished	   respectively	  by	  THO	  and	  TREX	   complex.	  The	  THO/TREX	  complex	   is	   responsible	   for	   packaging	   of	   pre-­‐mRNA	   with	   RNA-­‐binding	   proteins.	  These	   proteins,	   when	   mutated	   in	   yeast	   give	   a	   hyperrecombination	   phenotype	  mediated	   by	   R	   loops	   (81).	   The	   role	   of	   these	   proteins	   in	   R	   loop	   formation	   can	   be	  explained	  with	  their	  property	  to	  bind	  co-­‐trascriptionally	  the	  nascent	  RNA	  bringing	  it	  toward	  the	  nuclear	  pore.	  In	  the	  absence	  of	  these	  key	  proteins,	  RNA	  is	  free	  and	  may	  invade	  the	  DNA	  duplex	  behind	  a	  transcribing	  RNA	  polymerase.	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The	  last	  but	  not	  the	  least	  class	  of	  proteins	  that	  can	  prevent	  R	  loop	  formation	  are	  the	  
splicing	   factors.	   From	   a	   screening	   of	   siRNA	   libraries	   aimed	   to	   identify	   factors	  involved	   in	   genome	   instability,	   factors	   involved	   in	   splicing	   resulted	   the	   most	  represented	   class	   (82).	   Among	   them	   ASF/SF2	   was	   the	   first	   characterized:	   when	  depleted	  this	   factor	   lead	  to	  R	   loop	   formation	  and	  genomic	   instability	  (83).	  We	  can	  find	  two	  rational	  explanations	  for	  the	  importance	  that	  splicing	  factors	  have	  in	  R	  loop	  formation.	  First,	  in	  a	  manner	  similar	  to	  THO/TREX,	  co-­‐transcriptional	  binding	  of	  the	  nascent	  RNA	  by	  splicesome	  sequesters	  RNA	  from	  invading	  the	  DNA	  duplex.	  Second,	  and	   maybe	   more	   importantly,	   by	   removing	   intronic	   sequence,	   splicing	   factors	  reduce	  the	  possibility	  of	  a	  nascent	  RNA	  to	  anneal	  perfectly	  to	  the	  DNA	  sequence.	  All	   the	   considered	   factors	   have	   been	   shown	   to	   induce	   genomic	   instability	   when	  depleted.	   The	   involvement	   of	   R	   loops	   in	   this	   process	   was	   always	   shown	   trough	  overexpression	   of	   RNAseH	   that	   reverse	   the	   instability	   phenotype.	  However	   direct	  evidence	   of	   an	   increased	   R	   loops	   formation	   and	   localization	   of	   these	   altered	  structures	   in	   the	   genome	   are	   still	   missing.	   One	   potential	   mechanism	   that	   could	  explain	  why	  R	  loops	  increased	  by	  depletion	  of	  these	  factors	  lead	  to	  breakage	  on	  DNA	  is	   explained	   in	   a	   really	   recent	   work	   published	   by	   Cimprich’s	   Lab.	   	   The	   group	  demonstrated	   in	   human	   cells	   that	  R-­‐loops	  induced	   by	   the	   absence	   of	  different	  factors,	  including	  the	  RNA/DNA	  helicases	  Aquarius	  (AQR)	  and	  Senataxin	  (SETX)	  and	  the	   splicing	   factor	   ASF/SF2	   or	   by	   the	   inhibition	   of	   topoisomerase	   I	   by	   CPT,	   are	  actively	  processed	   into	  DSBs	  by	   the	  nucleotide	  excision	   repair	   endonucleases	  XPF	  and	   XPG.	   The	   entire	   TC-­‐NER	   pathway	   (and	   not	   the	   GG-­‐NER)	   was	   shown	   to	   be	  involved	   in	   this	  process	  (84).	  This	   is	   the	   first	  study	  that	  shows	  the	  possibility	  of	  a	  unique	  mechanism	  underlying	  the	  R	  loop-­‐driven	  instability.	  	  
1.2.8	  R	  loops	  as	  regulators	  of	  gene	  expression	  In	  spite	  of	  their	  role	  in	  genomic	  instability,	  recent	  studies	  have	  brought	  light	  to	  new	  potential	  roles	  that	  these	  structure	  could	  have	  in	  regulating	  transcription	  and	  gene	  expression.	  The	   first	   physiological	   role	   of	  R	   loop	  was	  uncovered	   in	  2003.	  Yu	   et	   al	  demonstrated	   that	   R	   loop	   forms	   at	   physiological	   level	   at	   Immunoglobulin	   heavy	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chain	  locus	  in	  activated	  B	  lymphocytes	  and	  these	  phenomenon	  triggers	  CSR	  switch	  class	   recombination.	   The	   length	   of	   these	   R	   loops	   can	   exceed	   over	   1	   kb	   (85).	   This	  paper	  suggested	  for	  the	  first	  time	  that	  the	  substrate	  to	  promote	  CSR	  by	  AID	  enzyme	  could	  be	  an	  R	  loop	  (74).	  	  Another	  potential	  role	  on	  gene	  expression	  was	  given	  by	  Chedin’s	  lab.	  They	  provided	  evidence	   for	   wide-­‐spread	   R	   loop	   formation	   over	   5’	   regions	   downstream	   of	   CpG	  Islands	  promoters.	  This	  R	  loop	  formation	  is	  driven	  by	  sequence	  and	  they	  form	  when	  the	   template	   strand	   is	   rich	   in	   C.	   Intriguingly	   R	   loop	   formation	   at	   CpG	   Island	  promoters	  seems	  to	  protect	  them	  against	  methylation	  (86)	  (87).	  A	   third	   and	   important	   role	   identified	   for	  R	   loops	   comes	   from	  Proudfoot’s	   lab	   and	  involves	  the	  transcriptional	  termination	  process.	  This	  group	  found	  that	  R	  loop	  forms	  at	   termination	   regions	   at	   levels	   of	   GC	   reach	   regions.	   This	  R	   loop	   slow	  down	  PolII	  downstream	  of	  the	  PolyA	  site.	  Then	  this	  structure	  has	  to	  be	  resolved	  by	  senataxin	  to	  promote	   Xrn2-­‐mediated	   transcript	   degradation	   and	   efficient	   termination	   (88).	  Intriguingly	  R	  loops	  at	  terminator	  sites	  induce	  repressive	  chromatin	  marks	  via	  RITS	  complex,	   to	   promote	   efficient	   termination	   (19).	   	   Finally,	   a	   really	   recent	   paper	  demonstrated	  that	  senataxin	  is	  recruited	  to	  terminator	  site	  trough	  interaction	  with	  the	  tumour	  suppressor	  BRCA1.	  The	  latter	  repair	  the	  R	  loop-­‐driven	  DNA	  damage	  at	  terminator	   sites	   (89).	   These	   data	   suggest	   that	   physiological	   and	   aberrant	   R	   loops	  are	  strictly	  connected,	  and	  deregulation	  of	  one	  of	  the	  involved	  factors	  could	  switch	  the	  physiological	  state	  into	  a	  “dangerous	  situation”.	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Chapter	  	  II	  
	  
MATERIAL	  and	  METHODS	  	  
	  
2.1	  Cell	  lines	  The	  cell	  lines	  HCT116,	  PC3,	  HEK293,	  NHDF,Ntera2	  were	  purchased	  from	  ATCC	  (LGC	  Standards	  S.r.l.,	  Milan,	  Italy)	  and	  were	  grown	  in	  Dulbecco’s	  modified	  Eagle’s	  medium	  (HCT116,	  HEK293,Ntera2,	  NHDF)	   or	  RPMI	   (PC3)	  mediums	  with	   10%	   fetal	   bovine	  serum	  and	  glutamine	  2mM.	  HCT116-­‐shRNATop1	  cell	  line	  was	  gently	  provided	  by	  Y.	  Pommier	   (NCI,	   Bethesda,	   MD,	   USA)	   and	   was	   grown	   as	   HCT116	   cells	   but	   in	   the	  presence	  of	  200	  μg/ml	  Hygromycin	  B.	  The	  cell	  line	  stably	  expresses	  a	  short	  hairpin	  RNA	   targeting	   exon	   17	   in	   the	   TOP1	   gene.Cells	   were	   maintained	   at	   37°C	   in	   a	  humidified	  incubator	  containing	  20%	  O2	  and	  5%	  CO2.	  Cell	  line	  identity	  was	  certified	  with	  Cell	  ID	  System	  (Promega)	  by	  BMR	  Genomics	  Srl	  (Padova,	  Italy).	  	  
	  
2.2	  Drugs	  and	  Antobodies	  Triptolide,	   MG132,	   Camptothecin	   and	   Aphidicolin	   were	   purchased	   from	   Sigma	  Aldrich,	   dissolved	   in	   dimethyl	   sulfoxide	   (Sigma)	   and	   stored	   at	   -­‐20°	   (except	   for	  MG132	   stored	   at-­‐80°)	   Drug	   aliquots	   were	   thawed	   immediately	   before	   each	  experiment.	   RPB1	   (CTD	   repeat),	   phospho-­‐Ser-­‐2-­‐RPB1,	   phospho-­‐Ser-­‐5-­‐RPB1	  antibodies	   were	   from	   Abcam,	   CDK7,	   B-­‐actin,	   Top1	   (c-­‐15),	   RPB1	   (H-­‐224),	   H1	   and	  gH2AX	  antibodies	  were	  from	  Santa	  Cruz	  Biotechnology.	  S9.6	  antibody	  was	  purified	  from	  a	  mouse	  hybridoma	  (clone	  HB8730)	  from	  ascetic	  fluids	  as	  previously	  reported.	  	  
2.3	  Cell	  treatments	  	  
For	   Triptolide	   experiments:	   Exponentially	   growing	   cells(75%	   of	   confluence)	   were	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exposed	   to	   10	   μM	   or	   100nM	   of	   Triptolide	   for	   the	   indicated	   time	   before	   protein	  extraction	  or	  formaldehyde	  fixation.	  	  
For	  Camptothecin	  experiments:	  Exponentially	  growing	  cells	  were	  exposed	  to	  10	  μM	  CPT.	   In	   case	   of	   co-­‐treatment,	   cells	  were	   incubated	  with	   aphidicolin	   (5	   μM)	   for	   15	  min,	  then	  CPT	  (10	  μM)	  was	  added	  to	  the	  medium	  for	  the	  indicated	  time.	  
	  
	  
2.4	  Knockdown	  experiments	  
CDK7	   knockdown:	   PC-­‐3	   cells	   were	   plated	   at	   18000	   cells/cm2	   density.	   Cells	   were	  transfected	   24	   hours	   after	   the	   plating	   with	   the	   RNAiMax	   transfection	   reagent	  (1:1000)	   and	   20	   nmol/L	   of	   scramble	   siRNA	   or	   CDK7	   siRNA	   (Invitrogen).	   CDK7	  silencing	   assessment	   and	   triptolide	   treatments	   were	   conducted	   72	   hours	   after	  transfection.	  
CDK9	  and	  Top1	  knockdown:	  HCT116	  cells	  were	  transfected	  24	  h	  after	  plating	  (30%	  confluence)	  with	  RNAiMax	  Transfection	   reagent	   (Life	  Technologies)	   and	  20	  nM	  of	  scramble	  siRNA	  or	  CDK9	  siRNA	  or	  Top1	  siRNA	  (targeting	  exon	  16	  of	  the	  TOP1	  gene;	  Life	   Technologies).	   Proteins	   silencing	   and	   drugs	   treatment	   were	   performed	   72	   h	  post-­‐transfection.	  	  
Top1	  double	  knockdown:	  HEK293	   cells	  were	   plated	   at	   16000	   cells/cm2	   density.	   A	  first	   round	   of	   transfection	   was	   performed	   24	   hours	   post	   seeding	   with	   10	   nM	   of	  scramble	   or	   Top1	   specific	   siRNA	   (targeting	   exon	   16	   of	   the	   TOP1	   gene;	   Life	  Technologies).	   48	   hours	   after	   transfection	   1/3	   of	   cells	   were	   transfected	   in	  suspension	   (reverse	   transfection)	   with	   10	   nm	   of	   the	   same	   siRNA.	   Top1	   silencing	  testing	   and	   genomic	   DNA	   extraction	   were	   performed	   72	   h	   post-­‐second	   round	   of	  transfection.	  	  
	  
	  
2.5	  Nuclear	  protein	  extract	  preparation	  Cells	   were	   washed	   twice	   with	   Ice-­‐cold	   PBS	   scraped	   and	   resuspend	   in	   hypotonic	  buffer	  (Hepes	  10	  mM,	  NaCl	  50	  mM,	  EDTA	  1	  mM,	  DTT	  1	  mM,	  Aprotinin,	  Leuppetin,	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Pepstatitin	   10	   mg/ml),	   PMSF	   1mM,	   NP-­‐40	   0.2%)	   for	   30’.	   Nuclear	   pellet	   was	  resuspended	   in	   hypertonic	   buffer	   (Hepes	   10	   mM,	   NaCl	   420	   mM,	   EDTA	   1	   mM,	  Glycerol	  10%,	  Aprotinin,	  Leuppetin,	  Pepstatitin	  10	  mg/ml),	  PMSF	  1mM)	  at	  4	  degrees	  in	  gentle	  rotation	  for	  30’.	  Cellular	  debris	  and	  DNA	  were	  pelleted	  by	  centrifugation	  at	  4	  degrees	  18000	  g.	  	  Supernatants	  were	  recovered	  and	  stored	  at	  -­‐80	  °C.	  
	  
	  
2.6	  Histones	  extraction	  Cells	   were	   washed	  	  twice	   with	   ice-­‐cold	   PBS	   scraped	  	  and	   	   lysed	   with	   Lysis	  buffer	  [10	   mM	   Tris-­‐HCl	   (pH	   7.5),	   1	   mM	   MgCl2,	   0.5%	   NP-­‐40]	   containing	   protease	  inhibitors	   [aprotinin,	   leupeptin,	   pepstatin	   (10	   mg/ml)	   and	   Phosphatase	   Inhibitor	  Cocktail	   II	   (Sigma)].	  Cellular	  debris	  were	  pelleted	  by	  centrifugation	  at	  16,000	  g	   for	  1	   min	   at	   4°C,	   resuspended	   and	   incubated	   for	   15	   min	   with	   Lysis	   buffer	   with	   400	  mM	   NaCl.	   Samples	   were	   briefly	   centrifugated,	   and	   pellets	   were	   incubated	   for	   10	  min	  at	   4°C	  with	  5	  volumes	  of	  Extraction	  solution	  [220	  mM	  H2SO4,	  20%	  Glycerol,	  10	  mg/mL	   2-­‐mercaptoethanolammine].	   	   The	   	   histone-­‐containing	   	   supernatant	   	   was	  	  obtained	  	   bycentrifugation	  at	  16,000	  g	  for	  10	  min.	  Histones	  were	  pelleted	  from	  the	  supernatant	  by	  adding	  20%	  trichloroacetic	  acid,	  and	  centrifugation.	  Then	  the	  pellets	  were	  resuspended	  in	   100%	   ethanol	   and	   centrifuged	   again	   at	   16,000	   g	   for	   20	  min.	  The	  pelleted	  histones	  were	  store	  at	  -­‐80	  °C.	  	  
	  
2.7	  Western	  Blot	  analysis	  Nuclear	   lysates,	   corresponding	   to	   20	   μg	   of	   proteins	  were	   separated	   by	   6.5%	  SDS	  PAGE.	   Proteins	   were	   then	   blotted	   onto	   a	   Hybond	   ECL-­‐nitrocellulose	   membrane.	  Histone	   aliquots,	   corresponding	   to	   10-­‐15	   μg	   were	   loaded	   onto	   a	   12%	   SDS-­‐PAGE	  gel,	   and	   then	   transferred	   to	   a	   Hybond	   ECL-­‐nitrocellulose	   membrane.	   Equal	  loading	  was	   checked	  with	  anti-­‐beta	  actin	  for	  nuclear	  extracts	  and	  anti-­‐histone	  H1	  antibodies	   for	   histones	   lysate.	   Specific	   bands	   were	   then	   detected	   with	   ECL	   Plus	  Western	   blot	   imaging	   system	   (GE	   Healthcare).	   Horseradish	   peroxidase-­‐
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conjugated	   mouse	   and	   rabbit	   IgG	   (1:2,000	   and	   1:5,000	   dilution	   respectively)	  were	   purchased	   from	   GE	   Healthcare.	   Horseradish	   peroxidase-­‐conjugated	   goat	  	  (1:40,000	   diluition)	  was	  	  from	   Santa	   Cruz	  Biotecnology.	  	  
	  
2.8	  RNA	  extraction	  and	  RT	  PCR	  After	   drug	   treatments,	   5x107	   	   	   cells	   	   were	   washed	   	   twice	   with	   cold	   PBS	   	   and	  collected	  through	  centrifugation.	  The	  pellet	  was	  frozen	  at	  -­‐80	  degrees	  for	  at	  least	  1	  hour	  and	  then	  resuspended	  and	  in	  3.6	  ml	   AE	  buffer	  [50	  mM	  NaOAc	  (pH	  5.2),	  10	  mM	  EDTA],	  240	  ml	  of	  SDS	  25%	  and	  3.6	  ml	   of	   acid	   phenol	   (pH	   4.5).	   Samples	  were	   then	  incubated	   for	   10	   min	   at	   65°C	   mixing	   vigorously	   every	   minute.	   After	   5’	   of	  incubation	   on	   ice,	   samples	   were	   centrifuged	   for	   15	   min	   at	   12,000	   g.	   The	   upper	  phase	  was	   collected;	   3.9	  ml	   of	   chloroform/isoamylic	  alcohol	  was	  added	   to	   it,	   then	  mixed	   and	   centrifuged	   for	   10	   min	   at	   1,800	   g.	   The	   upper	   phase	   was	   precipitated	  with	   isopropanol	   and	   NaOAc.	   The	   pellet	   was	   resuspended	   in	   TE,	   and	   DNA	   was	  digested	   with	   DNAse	   I	   (Thermo	   Scientific).	   RNAs	   were	   subsequently	   purified	  with	  phenol	  and	  precipitated	  with	  ethanol	  and	  NaOAc.	  RNA	   integrity	   was	   routinely	  checked	   by	   running	   1%	   agarose	   denaturating	   gel	   electrophoresis.	   Then,	   1	  mg	  of	  total	  RNA	  was	  used	  to	  prepare	  cDNA	  using	  SuperScript	  III	  (Invitrogen)	   with	  reaction	  buffers	  suggested	  by	  the	  manufacturer,	  for	  5	  min	  at	  65°C,	  5	  min	  at	  25°C,	  and	  60	  min	  at	   50°C,	   followed	   by	   alkaline	   hydrolysis	   	  with	  NaOH.	   cDNA	  was	   precipitated	  with	  EtOH	  precipitation.	  
	  
	  
2.9	  Quantitative	  Real-­‐Time	  PCR.	  	  Real-­‐time	  PCR	  were	  performed	  using	  LightCycler	   and	  FastStart	  DNA	  Master	   SYBR	  Green	  I	  kit	  (Roche	  Diagnostics,	  Mannheim)	  or	  Biorad	  CFX96	  Touch	  instrument	  and	  SsoI	  Universal	  Master	  Mix	  (Biorad).	  Quantification	  and	  melting	  curve	  analyses	  were	  performed	   using	   Roche	   LightCycler	   software	   or	   Biorad	   CFX	  Manager	   Software	   as	  indicated	  by	   the	   supplier.	   PCR	   reactions	   contained	  1x	  Master	  Mix	   	   and	  400	  nM	  of	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each	  primer.	  Specificity	  of	  PCR	  products	  was	  routinely	  controlled	  by	  melting	  curve	  analysis	  and	  agarose	  gel	  electrophoresis.	  
	  
	  
2.10	  Chromatin	  Immunoprecipitation	  	  For	   chromatin	   extraction,	   1x107cells	   (PC3	   or	   HEK293)	   were	   fixed	   with	   1%	  formaldehyde	  for	  15	  min.	  The	  reaction	  was	  stopped	  with	  125	  mM	  glycine	  and	  cells	  were	  washed	   twice	  with	   ice-­‐cold	   PBS.	   For	   triptolide	   experiments,	   PC3	   cells	   were	  then	  washed	  with	  7	  ml	   of	  TEET	   [10	  mM	  Tris-­‐HCl	   (pH	  8.0)	   10	  mM	  EDTA,	   0.5	  mM	  EGTA,	  0.25%	  Triton	  X-­‐100],	  5	  ml	  of	  TEEN	  [10	  mM	  Tris-­‐HCl	  (pH	  8.0)	  10	  mM	  EDTA,	  0.5	  mM	  EGTA,	  200	  mM	  NaCl],	  and	  resuspended	   in	  0.5	  ml	  of	  TEE	   [10	  mM	  Tris-­‐HCl	  (pH	  8.0)	  10	  mM	  EDTA,	  0.5	  mM	  EGTA].	  For	  Top1	  knockdown	  experiments,	  HEK293	  were	   directly	   lysed	   in	   TEE-­‐SDS	   1%.	   Protease	   inhibitors	   [aprotinin,	   leupeptin	   and	  pepstatin	   (Sigma)	   10	  mg/ml]	   were	   added	   to	   the	   buffers	   immediately	   before	   use.	  Chromatin	  was	  then	  fragmented	  by	  sonication	  using	  a	  Bioruptor	  (Diagenode)	  to	  an	  average	  DNA	  fragment	  size	  of	  300–400	  bp.	  Immunoprecipitations	  were	  performed	  at	  4°C	  in	  RIPA	  buffer	  [50	  mM	  Tris-­‐HCl	  (pH	  8.0),	  1	  mM	  EDTA,	  0.5	  mM	  EGTA,	  150	  mM	  NaCl,	   1%	  Triton	  X-­‐100,	   0.1%	  Na-­‐deoxycholate,	   0.1%	  SDS].	   Amounts	   of	   chromatin,	  equivalent	  to	  0.4	  U.A	  at	  260	  nm	  were	  taken	  for	  each	  immunoprecipitation.	  Samples	  were	  precleared	  for	  2	  hour	  with	  4	  μg	  of	  non-­‐immune	  rabbit	   IgG	  and	  20	  μl	  of	  50%	  suspension	  of	  a	  1:1	  mix	  of	  Protein	  A-­‐	  and	  Protein	  G-­‐Sepharose	  beads.	  Then,	  beads	  were	  descarted	  and	  chromatin	  was	  recovered	  by	  centrifugation	  for	  3	  min	  at	  1,000g.	  20%	   of	   the	   supernatants	   were	   saved	   as	   input.	   Supernatants	   were	   incubated	  overnight	   with	   4	   μg	   of	   specific	   antibody	   or	   nonimmune	   rabbit	   IgG	   (to	   measure	  aspecific	  recovery).	  ChIP-­‐grade	  ab	  for	  Rbp1	  (the	  largest	  subunit	  of	  RNA	  Polimerase	  II	  against	  the	  N	  term	  (H224))	  was	  from	  Santa	  Cruz	  Biotechnology	  (Santa	  Cruz,	  CA).	  Non-­‐immune	   rabbit	   IgG	   were	   from	   Jackson	   (West	   Grove,	   PA,	   USA).	  Immunocomplexes	  were	   recovered	   by	   addition	   of	   40	  ml	   of	   Protein	   A-­‐/Protein	   G-­‐Sepharose	  beads	  blocked	  with	  DNase-­‐free	  BSA	  (9.95	  mg/ml)	  and	  salmon	  testes	  DNA	  (10.5	  mg/ml).	  Then,	  the	  beads	  were	  washed	  four	  times	  with	  RIPA	  buffer;	  once	  with	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RIPA	  buffer	  containing	  0.5	  M	  NaCl;	  once	  with	  Li250	  buffer	  [10	  mM	  Tris-­‐HCl	  (pH	  8.0),	  1	  mM	  EDTA,	  0.25	  M	  LiCl,	  0.5%	  Na-­‐deoxycholate,	  and	  0.5%	  NP40];	  twice	  with	  TE	  [10	  mM	  Tris-­‐HCl,	   1	  mM	  EDTA	  47	  pH	  8.0)];	   and	   finally	   resuspended	   in	  TE.	   Each	  wash	  was	  performed	  for	  10	  min	  by	  rocking	  at	  20	  rpm	  followed	  by	  3	  min	  of	  centrifugation	  at	  1,000g.	  The	  pellets	  were	   then	  adjusted	   to	  0.5%	  SDS	  and	   incubated	  overnight	  at	  65°C	   to	   reverse	   cross-­‐links.	   Samples	   were	   then	   digested	   with	   proteinase	   K	   (500	  mg/ml	   Sigma)	   for	   4	   h	   at	   52°C	   and	   extracted	   twice	  with	   phenol	   chloroform.	  DNAs	  was	   precipitated	   with	   ethanol	   in	   the	   presence	   of	   20	   μg	   of	   glycogen	   (Roche	  Diagnostics,	  Manheim)	  and	  dissolved	  in	  TE.	  Recovered	  DNA	  was	  quantified	  by	  real-­‐time	  PCR	  (see	  Table	  1	  for	  the	  list	  of	  primers).	  At	  least	  three	  dilutions	  of	  input	  DNA	  were	  run	  to	  generate	  the	  standard	  curve.	  DNA	  recovery	  was	  measured	  as	  input	  DNA	  fraction.	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2.12	  Genomic	  extraction	  for	  R	  loops	  detection.	  Cells	  were	  washed	  twice	  with	  ice-­‐cold	  PBS	  and	  directly	  lysed	  on	  the	  plate	  with	  TE-­‐SDS	   1%.	   DNA	   was	   collected	   in	   a	   15ml	   falcon	   and	   incubated	   overnight	   with	  Proteinase	  K	  (Roche)	  at	  70	  μg/ml.	  After	  overnight	  incubation	  DNA	  was	  precipitated	  with	  ethanol	  70%	  and	  sodium	  acetate	  0,3M	  pH	  5.0.	  DNA	  was	  recovered	  with	  a	  cut	  tip	  and	  washed	  5	  times	  in	  ethanol	  70%.	  Once	  dried,	  DNA	  pellet	  was	  resuspended	  in	  TE	  and	  digested	  with	  restriction	  enzymes	  cocktail	  (2	  units	  each:	  HindIII,	  EcoRI,	  XbaI,	  BsrgI,	  SspI)	  overnight	  at	  37	  degrees.	  After	  digestion	  fragment	  size	  was	  checked	  on	  agarose	  gel	  and	  DNA	  was	  stored	  at	  -­‐80	  degrees.	  
	  
	  
2.13	  Dot	  blot	  for	  detection	  of	  global	  levels	  of	  RNA:DNA	  hybrids	  6,5	  μg	  of	   genomic	  DNA	  was	  dissolved	   in	  800	  μl	   of	  ddH20.	  Two-­‐fold	  dilution	  were	  prepared	  in	  ddH20.	  1	  μg	  of	  diluted	  DNA	  was	  kept	  apart,	  precipitated	  and	  loaded	  on	  agarose	   gel	   as	   Input	   control.	   DNA	   dilutions	   were	   spotted	   on	   nitrocellulose	  membrane	   equilibrated	   in	   SSC	   2X	  with	   a	   vacuum	  dot	   blot	   apparatus..	  Wells	  were	  washed	  twice	  with	  SSC	  2X	  and	  DNA	  was	  crosslinked	  to	  the	  membrane	  with	  an	  UV	  crosslinker	   at	   12,0000	   	   μJ/cm2	   for	   10-­‐15	   s.	   Membrane	   was	   blocked	   for	   30’	   with	  	  blocking	   buffer	   (PBS	   1x,	   BSA	   3%,	   tween	   0,1%)	   and	   then	   incubated	   for	   two	   hours	  with	   s9.6	   antibody	   (1:1000	   in	   blocking	   buffer)	   	   at	   RT	   in	   gentle	   shaking.	   Three	  washings	  were	  performed	  with	  PBS-­‐tween	  0.1%	  and	  then	  membrane	  was	  incubated	  with	  Alexa	  fluor	  anti-­‐mouse	  secondary	  antibody	  (1:10000	  in	  blocking	  buffer).	  After	  three	  washing	  in	  PBS-­‐tween	  0.1%	  membrane	  was	  scanned	  din	  Licor	  scanner.	  
	  
	  
2.14	  DRIP:	  DNA-­‐RNA	  Immunprecipitation	  	  4,445	  μg	   of	   genomic	  DNA	  were	  diluted	   in	   500	  μl	   of	   TE	   (Tris	   10mM,	  EDTA	  1mM).	  445ng	  of	  the	  diluted	  DNA	  was	  used	  as	  INPUT	  while	  4	  μg	  were	  incubated	  with	  10	  μg	  of	  s9.6	  ab	  in	  binding	  buffer	  (10	  mM	  NaPO4	  pH	  7.00,14	  M	  NaCl0.05%	  Triton	  X-­‐100)	  overnight	   	   at	   4	   degrees	   in	   gentle	   rotation.	   16	   hours	   later	   50	   μl	   of	   Protein	   A/G	  
	   	   39	  
sepharose	  beads	  (Pierce)	  were	  equilibrated	  in	  binding	  buffer	  three	  times	  and	  used	  to	  capture	  immunocomplex	  trough	  gentle	  rotation	  at	  4	  degrees	  for	  two	  hours.	  Beads	  were	  washed	   three	   times	  with	  binding	  buffer	   for	  10	  minutes	   in	   gentle	   rotation	  at	  RT.	  Eluition	  were	  performed	   trough	   incubation	  with	  proteinase	  k	   (500	  μg/ml)	   for	  45’	   at	   55	  degrees.	   	   Reactions	  were	   cleaned	  up	  with	  phenol/chloroform	  extraction	  and	   DNA	   was	   precipated	   with	   ethanol,	   sodium	   acetate	   and	   glycogen.	   R	   loop	  recovery	  and	  IP	  efficiency	  were	  assessed	  by	  Real	  time	  PCR.	  	  
	  
2.15	  DRIPc:	  DNA-­‐RNA	  Immunoprecipitation	  coupled	  to	  RT.	  DRIPc	  analysis	  was	  performed	  on	  immunoprecipitated	  DNA	  derived	  from	  at	  least	  8	  DRIPs.	   DNA	   was	   treated	   with	   4	   units	   of	   DNAse	   I	   (NEB)	   for	   40’	   at	   37	   degrees.	  Reaction	  was	  stopped	  by	  adding	  EDTA	  50	  mM	  and	  incubating	  at	  75	  degree	  for	  10’.	  RNA	   isolated	  was	   then	   precipitated	  with	   EtOH,	  NaOAC	  ph5.2	   and	   glycongen.	   RNA	  was	   then	  used	   for	   a	   retrotranscription	   reaction.	   Iscript	  RT	   (biorad	   )	   protocol	  was	  used	  for	  first	  strand	  synthesis	  according	  to	  manufacturer	  directions.	  Zymo	  column	  were	   used	   to	   clean	   up	   the	   RT	   reactions.	   Second	   strand	   synthesis	   was	   performed	  using	  10	  units	  of	  DNA	  polymerase	  and	  1.6	  units	  of	  RNAseH	  (NEB)	  and	  E.	  coli	  DNA	  ligase.	   Replacing	   dTTP	   with	   dUTP	   performs	   reaction	   allowed	   labeling	   of	   second	  strand	  with	  uridine.	  Raection	  was	  cleaned	  up	  again	  with	  Zymo	  columns.	  	  	  
2.16	  Library	  Preparation	  for	  ChIPseq,	  DRIPseq	  and	  DRIPc	  seq	  DNA	  from	  ChIP	  was	  directly	  used	  for	  library	  preparation	  as	  already	  sheared	  at	  the	  desired	  size	   level	   (300-­‐500	  bp).	  DNA	   from	  DRIP	  and	  DRIPc	  was	   instead	  sonicated	  using	   Bioruptor	   from	   Diagenode	   using	   the	   following	   protocol:	   HIGH	   intensity	   10	  cycles	   15	   s	  ON/	  90	   sec	  OFF.	   End	   repair	  was	   performed	  using	  NEB	   repair	  module	  cocktail	  in	  the	  presence	  of	  ATP	  at	  RT	  for	  30’.	  Reaction	  was	  cleaned	  up	  with	  Qiagen	  PCR	   clean	   up	   columns.	   A-­‐tailing	   was	   realized	   by	   using	   Knleow	   fragment	   without	  exonuclease	   activity	   in	   the	   presence	   of	   dATP.	   And	   followed	   by	   purification	   with	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MinELute	   Quiagen	   columns.	   Illumina	   Truseq	   RNA	   adapters	   were	   added	   by	   quick	  ligation	   (NEB)	   and	   size	   selection	   was	   performed	   to	   exclude	   adapters	   ligation	  products.	  qPCR	  with	  primers	  on	  adapters	  was	  performed	  to	  understand	  number	  of	  cycles	  of	  PCR	  for	  a	  good	  library	  amplification.	  At	  this	  point	  for	  strand	  specific	  DRIPc	  	  DNA	   libraries	  were	   treated	  with	  UNG	  glycosidase	   to	  degrade	  U	   labeled	  strand.	  On	  the	  basis	  of	  qPCR	  results	  library	  were	  amplified	  using	  Primers	  for	  Trueseq	  adapters	  and	  Phusion	  2X	  HF	  master	  mix	  with	  the	  following	  protocol;	  10	  sec	  at	  98	  degrees,	  30	  sec	  at	  60	  degrees	  and	  30	  sec	  at	  72	  degrees	  (	  for	  13-­‐16	  cycles)	  and	  5’	  at	  72	  degrees.	  Size	  exclusion	  using	  Ampure	  removes	   fragments	   less	   long	   than	  200	  bp	  and	   longer	  than	   500	   bp.	   Library	   quality	   and	   quantitation	   was	   checked	   with	   Byoanalyzer	  (Agilent).	   Deep	   sequencing	   was	   performed	   by	   Computational	   Genomics	   Resource	  Laboratory,	  University	  of	  Berkley.	  	  	  	  
	  
2.17	  RNAseq	  libraries	  preparation.	  Total	   RNA	   was	   extracted	   after	   72	   hous	   post-­‐second	   round	   of	   transfection	   using	  Direct-­‐zol	  RNA	  Mini-­‐prep,	  quantified	  and	  quality	  checked	  on	  denaturating	  agarose	  gel.	   Total	   RNA	   libraries	   preparation	   and	   Deep	   sequencing	   were	   peformed	   by	  Computational	  Genomics	  Resource	  Laboratory,	  University	  of	  Berkley.	  	  	  
	  
2.18	  DRIP-­‐seq,	  DRIPc-­‐seq	  and	  PolII	  ChIP-­‐seq	  bioinformatic	  analysis	  Sequencing	  reads	  were	  trimmed	  using	  FastqMcf	  and	  mapped	  to	  the	  hg19	  reference	  human	  genome	  using	  BWA	  version	  0.6.1-­‐r104	  (90).	  For	  DRIPc,	  mapped	  reads	  were	  assigned	   to	   plus	   or	   minus	   strand	   using	   SAMtools	   (91).	   To	   normalize	   between	  different	  samples,	  equal	  number	  of	  mapped	  reads	  for	  each	  sample	  was	  used	  for	  all	  downstream	   analysis.	   Peak	   calling	  was	   performed	   using	   a	   custom	   7-­‐state	   Hidden	  Markov	  Model	  coupled	  to	  a	  Genetic	  Algorithm	  (unpublished	  software).	  TSS,	  TTS	  and	  gene	  metaplots	  were	  generated	  using	  custom	  Perl	  and	  R	  scripts.	  All	  overlap	  analysis	  was	  performed	  using	  BEDTools	  (92).	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3.1	  Effects	  of	  Triptolide	  on	  Rbp1	  stability	  
	  
3.1.1	  	  Triptolide	  induces	  Ser5	  hyperphosphorylation	  prior	  to	  RNA	  
	  	  	  	  	  	  	  	  	  	  	  Polymerase	  II	  decrease.	  To	   investigate	   how	   triptolide	   (TPL)	   can	   affect	   RNA	   Polymerase	   II	   stability	   we	  decided	   to	  assess	   levels	  of	   total	  RNA	  polymerase	  and	   levels	  of	  phosphorylation	  of	  PolII-­‐CTD	  during	  triptolide	  treatment.	  Figure	  1	  shows	  that	  degradation	  of	  Rpb1,	  the	  largest	   subunit	   of	   RNA	   Polymerase	   II,	   induced	   by	   triptolide	   is	   dose	   and	   time	  dependent.	  Particularly,	  focusing	  on	  time	  course,	  at	  early	  time	  of	  treatment	  (2h)	  the	  PolII	   reduction	   is	   minor	   as	  compared	   to	   control.	   Rpb1	  levels	   start	   decreasing	   at	  later	  stages	  of	  treatment	  with	  TPL	   100	   nM	   (3-­‐4	   h).	  Interestingly,	   western	   blot	  analysis	   using	   antibodies	  specific	   for	   phosphorylated	  forms	  (Ser	  2	  and	  Ser5)	  of	  the	  carboxyl	   terminal	   domain	   of	  PolII	   reveal	   that	   at	   early	  times	   of	   treatment	   PolII	  reduction	   is	   preceded	   by	   a	  hyperphoshorylation	  event	  of	  Fig	   1.Triptolide	   induces	   hyperphosphorylation	   of	   Ser5	   on	   PolII-­‐CTD	  preceding	   RPB1	   degradation	   Western	   blot	   analysis	   to	   detect	   Rpb1	  levels	   and	   phosphorylation	   state	   of	   CTD	   of	   POlII	   .during	   triptolide	  treatment.	  B	  actin	  is	  used	  as	  loading	  control	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Ser5	  on	  CTD.	  Notably	  Ser2	  levels	  do	  not	  change	  until	  6h	  of	  treatment,	  when	  lower	  bands	  for	  this	  residue	  can	  be	  detected,	  probably	  due	  to	  hypophosphorylating	  events.	  This	  data	  suggest	  the	  possibility	  that	  the	  degradation	  of	  RNA	  Polymerase	  II	  induced	  by	   triptolide	   can	   be	   an	   event	   triggered	   by	   an	   hyperphosphorylation	   of	   CTD,	  particurarly	  at	  Ser5	  sites.	  	  	  
3.1.2 Triptolide	  induces	  block	  of	  RNA	  Polymerase	  II	  at	  promoters	  of	  	  
active	  genes.	  Western	   blot	   analysis	   demonstrated	   that	   total	   levels	   of	   RNA	   Polymerase	   II	  
Fig	  2.	  Triptolide	  induces	  a	  decrease	  of	  chromatine	  bound	  PolII	  at	  promoters	  of	  active	  genes.	  ChIP	  experiments	  performed	  using	  a	  specific	  ab	  against	  N	  term	  of	  RPB1	  with	  chromatine	  extracted	  from	  PC3	  cells	  control	  and	  treated	  with	  TPL	  1	  μM	  2	  h	  (A)	  and	  100	  nM	  up	  to	  4	  hours	  (B).	  Recovery	  are	  normalized	  on	  control	  cells.	  Significance	  was	  calculated	  with	  t	  student	  test	  with	  *	  =	  	  P<0,05.	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decreased	   during	   triptolide	   treatment	   in	   a	   time	   dependent	   manner,	   and	   this	  reduction	   follows	   a	   hyperphosphorylation	   event	   at	   level	   of	   Ser5	   of	   CTD.	   To	  understand	   if	   this	   reduction	   involves	   also	   chromatin	   bound	   fraction	   of	   PolII	   we	  performed	   ChIP	   experiment	   using	   an	   antibody	   against	   N	   terminal	   of	   Rpb1	   with	  chromatin	   extracted	   from	  PC3	   cells	   treated	  with	  different	  doses	   and	   times	  TPL	  of	  treatment.	  We	  first	  found	  that	  a	  treatment	  of	  2	  h	  with	  1	  μM	  of	  TPL	  is	  able	  to	  deplete	  more	   than	   90%	  of	   chromatin	  bound	  PolII	  at	  all	  the	   tested	  promoters	   of	  active	   genes	   (c-­‐
Myc,	   HIF1a,	  
Polr2a,VEGF)	  (Fig	  2a).	  	  Time	   course	  experiments	  with	  lower	   dose	   (100	  nM)	   showed	  reduction	   at	   the	  same	   loci	   in	   a	  time	   dependent	  manner	   (Fig	   2b).	  Intriguingly	  short	  times	   of	  treatments	   (2h)	  that	   correspond	  to	  hyperphosphorylation	   at	   Ser5	  Fig	   3.Triptolide	   induces	   a	   block	   of	   RNA	   Polymerase	   II	   at	   promoters	   of	   transcribed	   genes.	  ChIP	   experiments	   performed	   using	   a	   specific	   ab	   against	   N	   term	   of	   RPB1	   with	   chromatine	  extracted	  from	  PC3	  cells	  control	  and	  treated	  100	  nM	  up	  to	  4	  hours	  (B).	  Recovery	  are	  normalized	  on	   control	   cells.	   .a)c-­‐myc	   gene	   B)	   vegf	  gene	   C)	   hif1a	   gene	   Significance	   	   was	   calculated	   with	   t	  student	  test	  	  with	  *	  =	  	  P<0,05	  and	  **=	  	  P<	  0,01	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sites	  did	  not	  show	  reduction	  of	  PolII	  at	  promoters	  and	  in	  one	  case,	  even	  an	  increase	  of	  polII	  occupancy	  could	  be	  detected	  (polr2a).	  Since	  a	  PolII	  reduction	  at	  promoters	  could	   be	   due	   also	   to	   an	   increased	   escape	   of	   pol	   II	   from	   these	   regions,	   as	   already	  shown	   for	   Top1	   inhibitors	   (63),	   we	   decided	   to	   check	   	   PolII	   occupancy	   at	   exons	  levels.	   We	   found	   that	   TPL	   treatment	   induces	   PolII	   reduction	   both	   on	   exons	   and	  promoters	  levels,	  but	  at	  short	  times	  of	  treatment	  (1	  h	  100	  nM)	  PolII	  occupancy	  did	  not	   decrease	   at	   promoters,	   indeed	   even	   an	   increase	   for	   c-­‐myc	   promoter	   could	   be	  detected.	  Instead,	  at	  the	  corresponding	  gene	  exons	  a	  decrease	  of	  PolII	  presence	  was	  clearly	   detected	   at	   short	   times	   (Fig	   3).	   These	   data	   showed	   that	   short	   times	   of	  treatment	  and	  low	  doses	  of	  TPL	  induce	  a	  block	  of	  RNA	  polymerase	  II	  at	  promoter	  of	  active	  genes.	  	  
	  	  
3.1.3 CDK7	  mediates	  Triptolide	  induced	  reduction	  of	  RNA	  	  
Polymerase	  II	  The	  hyperphosphorylation	  event	  seen	  at	  short	  times	  of	  TPL	  treatments	  could	  be	  the	  key	   molecular	   event	   that	   induces	   PolII	   block	   at	   promoters	   and	   persistent	  degradation	   of	   Rpb1.	   The	   major	   kinase	   responsible	   for	   Ser	   5	   phosphorylation	   is	  CDK7,	   a	   cyclin	   dependent	   kinase	   that	   is	   part	   of	   the	   transcriptional	   factor	   TFIIH.	  Intriguingly,	   the	   pharmacological	   target	   of	   TPL	   is	   XPB,	   which	   is	   part	   of	   TFIIH	  complex.	   To	   understand	   if	   CDK7	   was	   responsible	   for	   the	   TPL-­‐induced	   Ser5	  hyperphosphorylation	   and	   if	   its	   kinase	   activity	   is	   important	   for	   Rbp1	   stability	  during	  TPL	   treatments	  we	  performed	  siRNA	  knockdown	  of	  Cdk7	   followed	  by	  TPL	  treatments.	  We	   found	   that	  downregulation	   	  of	  CDK7	  affects	  hyperphosphorylation	  of	  Ser5	  of	  CTD	  and	  that	  the	  following	  Rpb1	  degradation	  was	  partially	  rescued	  after	  the	  kinase	  silencing	  (Fig	  4a).	  Notably,	  PolII	  degradation	  was	  reversed	  even	  with	  high	  dose	   treatment	   of	   TPL	   (1	   μM	   2	   h)	   (Fig	   4b).	   ChIP	   experiments	   showed	   that	   CDK7	  knockdown	  protects	  chromatin	  bound	  PolII	  by	  TPL	  induced	  depletion	  (Fig	  4c).	  These	   data	   demonstrate	   that	   CDK7	   is	   involved	   in	   Rpb1	   stability	   during	   TPL	  treatments.	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Fig4.	   CDK7	   mediates	   TPL-­‐induced	   Ser5	   hyperphosphorilation	   and	   Rbp1	   degrdation.	   A)	   Western	   blot	   analysis	   on	  
nuclear	  extracts	  from	  cells	  treated	  with	  TPL	  100nm	  for	  2	  and	  4	  hours	  in	  the	  presence/absence	  of	  downregulation	  for	  CDK7.	  B)	  
Western	  blot	  from	  cells	  treated	  at	  high	  dose	  (1	  μM)	  of	  TPL	  for	  2hours.	  C)	  ChIP	  experiments	  for	  POlII	  on	  chromatin	  extracted	  
from	  cells	  treated	  with	  TPL	  2h	  1	  μM	  in	  the	  presence/absence	  of	  CDK7	  downregulation.	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3.2	  Transcriptional	  role	  of	  Top1:	  camptothecin-­‐induced	  Antisense	  	  
	  	  	  	  	  	  	  	  transcription	  and	  Top1-­‐mediated	  R	  loops	  stabilization	  	  
	  
3.2.1	  Camptothecin	  enhances	  antisense	  transcription	  at	  divergent	  	  
	  	  	  	  	  	  	  	  	  	  	  promoters.	   To	   better	   understand	   if	   the	  previously	   published	   findings	   about	  CPT-­‐induced	   antisense	   activation	  seen	  at	   the	  HIF1a	   locus	  was	   a	   single	  gene	  phenomenon	  or	  a	  more	  general	  mechanism,	  we	  performed	  a	  genome-­‐wide	  study	  of	  CPT-­‐induced	  variations	  in	   transcript	   levels	   by	   NGS	  techniques.	   RNAseq	   data	   were	  colected	  using	  RNA	  extracted	  from	  	  
	  HCT116	  cells	   control	  and	   treated	   for	  4	  hours	  with	  CPT	  10	  μM.	  Before	  sequencing,	  RNA	   was	   treated	   with	   bisulphite	   to	   maintain	   the	   strand	   specificity.	   With	   this	  approach	  we	  were	  able	  to	  identify	  256	  antisense	  transcripts	  located	  at	  CpG	  Islands	  	  
Fig	   5.	  CPT	   induces	  antisense	   transcription	   in	   a	  Top1	  dependent	  manner.	  A)	   RT-­‐PCR	  measuring	  antisense	   transcript	  levels	   in	   HCT116	   and	   HCT116	   Top1	   siRNA	   (stable	   clone)	   treated	   with	   different	   doses	   of	   CPT.	   B)	   RT-­‐PCR	   measuring	  antisense	  transcript	  levels	  in	  HCT116	  and	  HCT116	  transiently	  downregulated	  for	  Top1	  treated	  for	  4	  h	  with	  different	  doses	  of	  CPT.	  C)	  Western	  blot	  analysis	  to	  asses	  Top1	  levele	  in	  HCT116	  and	  HCT116	  Top1shRNA	  
C 
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  promoters.	   Notably	   these	   promoters	   were	   almost	   exclusively	   bidirectional	  promoters	   suggesting	   that	   CPT	   and	   Top1cc	   can	   interfere	   with	   directionality	   of	  promoter.	   We	   decided	   first	   to	   validate	   and	   characterize	   such	   transcripts.	   We	  randomly	   selected	   10	   loci	   to	   be	   validated	   by	   RT	   qPCR.	   Figure	   shows	   the	   fold	  increase	  of	  these	  transcripts	  after	  CPT	  treatment,	  demonstrating	  a	  good	  agreement	  with	  RNA	  seq	  data	  (FIG	  5	  A).	  Strand	  information	  obtained	  with	  primer	  specific	  RT	  revealed	  that	  these	  transcripts	  were	   effectively	   antisense	   to	   the	   gene	   mRNA	   (data	   not	   shown).	   The	   antisense	  activation	  was	  definitively	  reduced	  in	  HCT116	  cells	  stably	  downregulated	  for	  Top1	  (HCT116	  shRNA	  Top1)	  (Fig5	  A)	  suggesting	  that	  Top1	  is	  necessary	  for	  the	  CPT	  effect	  on	  antisense	   transcripts	   at	  bidirectional	  CpG-­‐island	  promoters.	   Same	   results	  were	  obtained	   when	   we	   performed	   a	   transient	   Top1	   knockdown:	   Fig	   5B	   show	   that	  transient	   knockdown	   induce	   a	   decrease	   on	   antisense	   activation	   at	   almost	   all	   the	  tested	  loci.	  Notably	  the	  simple	  downregulation	  of	  Top1	  does	  not	  induce	  antisense	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  
	  Fig	   6.	  CDK9	  mediates	  CPT-­‐induced	  antisense	  activation.	   A)	  RT-­‐qPCR	  meausuring	  antisense	   transcript	  levels	  in	  the	  presence	  of	  downregulation	  of	  CDK9	  B)Western	  blot	  analysis	  to	  assess	  CDK9	  knockdown	  
A 
B 
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  enhancement	  suggesting	  that	  Top1cc	  formation	  is	  essential	  for	  this	  mechanism.	  Since	  it	  has	  been	  shown	  that	  divergent	  transcription	  at	  bidirectional	  promoters	  can	  be	  regulated	  by	  the	  transcription	  elongation	  factor	  PTEFb	  we	  decided	  to	  studyCPT	  effects	  on	  antisense	  transcription	  following	  downregulation	  of	  CDK9,	  the	  kinase	  that	  is	  part	  of	  PTEFb	  and	  positively	  regulates	  elongation.	  Fig	  (6A)	  shows	  that	  transient	  CDK9	  knockdown	  partially	  suppressed	  antisense	  activation	  at	  almost	  all	  the	  tested	  loci.	   Suppression	   was	   not	   total,	   but	   significant,	   especially	   considering	   the	   partial	  knockdown	  of	  CDK9	  Fig	  (Fig	  6B)	  .	  Top1	   activity	   is	   crucial	   for	   correct	   transcription,	   but	   this	   enzyme	  plays	   important	  role	  in	  replication	  too.	  To	  better	  understand	  if	  replication	  could	  affect	  in	  some	  way	  CPT-­‐induced	  enhancement	  of	  antisense	  transcripts,	  we	  measured	  by	  RT	  qPCR	  CPT	  induced	  antisense	  transcripts	  levels	  in	  the	  presence	  of	  a	  DNA	  polymerase	  inhibitor	  aphidicolin,	   that	   usually	   blocks	   cells	   in	   early	   S	   phase.	   Aphidicolin	   reverses	   the	  replication-­‐dependent	  DNA	  damage	  induced	  by	  CPT.	  Fig	  7b	  shows	  that	  DNA	  damage	  marker	   γ-­‐H2AX	   is	   partially	   rescued	   by	  when	   cells	   are	   co-­‐incubated	  with	   CPT	   and	  aphidicolin.	   Fig	   7a	   shows	   that	   CPT	  was	   able	   to	   induce	   antisense	   activation	   in	   the	  presence	  of	  this	  replication	  inhibitor	  at	  almost	  the	  same	  extent	  of	  control	  cells.	  The	  antisense	   increase	   could	   be	   detected	   even	   with	   a	   lower	   dose	   of	   CPT,	   1	   μM,	   and	  aphidicolin	  was	  still	  not	  able	  to	  suppress	  the	  phenomenon	  .	  These	  data	  suggest	  that	  Top1	   inhibition	   by	   CPT	   perturbs	   transcription	   at	   bidirectional	   promoters	   in	   a	  replication	  independent	  and	  Top1/CDK9	  dependent	  manner.	  






3.2.2	  Top1cc	  induced	  by	  CPT	  parallels	  a	  transient	  increase	  of	  R	  loop	  	  
	  	  	  	  	  	  	  	  	  	  	  structures	  CPT	  is	  highly	  diffusible	  molecule.	  	  For	  this	  reason,	  it	  is	  able	  to	  penetrate	  cells	  really	  fast	  and	  entrap	  Top1	  on	  DNA	  during	  short	  times	  of	  treatment.	  Previously	  published	  evidence	   from	   our	   lab	   showed	   indeed	   that	   Top1ccs	   are	   formed	   within	   2’	   of	  treatment	  with	  CPT	  10	  μM	  at	  nuclear	  chromatin	  (ref).	  As	  CPT-­‐induced	  Top1cc	  can	  increase	   negative	   supercoiling	   at	   active	   promoters	   (REF),	   and	   negative	   supercoils	  
Fig	  7.	  Antisense	  activation	  induced	  by	  CPT	  is	  a	  replication	  independent	  process.	  A)RT-­‐qPCR	  measuring	  antisensen	   transcript	   levels	   in	   cells	   treated	   with	   two	   different	   concentration	   of	   CPT	   (1	   and	   10	   μM,	   4	  hours)	  in	  the	  presence/absence	  of	  	  aphidicolin.	  B)	  Western	  blot	  analysis	  with	  ab	  against	  γ-H2AX	  to	  detect	  CPT-­‐induced	  DNA	  damage.	  H1	  is	  used	  as	  loading	  control	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can	   favor	   the	   formation	   of	   non-­‐B	   DNA	   structures	   as	   R	   loops,	   we	   decided	   to	  investigate	  if	  R	  loops	  structures	  could	  be	  in	  some	  ways	  affected	  by	  CPT	  at	  promoters	  	  	  
	  	  	  	  
	  
D 
Fig	   8.	   Top1	   inhibition	   induced	   a	   burst	   of	   R	   loop	   structure	   at	   cellular	   levels	   at	   shorts	   time	   of	   CPT	  
treatments	  A)	  Immunofluorescence	  	  using	  s9.6	  ab	  on	  methanol	  fixed	  cells	  (HCT116	  and	  Fibroblast)	  treated	  for	   different	   times	   with	   CPT	   10	   μM.	   DAPI	   was	   used	   for	   nuclear	   staining.	   B)	   Fluorescence	   intensity	   	   for	  HCT116	  in	  A	  quantified	  with	  Image	  J.	  C)	  Immunofluorescence	  	  using	  s9.6	  ab	  on	  methanol	  fixed	  cells	  (HEK	  293	  and	  Ntera2	  )	  treated	  for	  short	  times	  with	  CPT	  10	  μM.	  	  D)	  ICE	  bioassay	  showing	  entrapment	  of	  Top1	  on	  DNA	  during	  short	  times	  of	  CPT	  treatments	  (10	  μM).	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showing	  an	  increase	  of	  antisense	  transcript	  levels.	  First,	   we	   performed	   immunofluorescence	   investigations	   using	   a	   specific	   antibody	  for	  RNA/DNA	  hybrids	   (s9.6	   ab).	   The	   results	   are	   showed	   in	   Figure	  8	   that	   partially	  represents	   our	   work	   recently	   published	   on	  Nucleic	   Acid	  Research	   (95).	  We	   found	  that	  short	   times	  of	   treatments	   (2-­‐5’)	  with	  10	  μM	  of	  CPT	   induce	  a	  burst	  of	  R	   loops	  structures	  at	  cellular	  level,	  particularly	  at	  highly	  transcribed	  regions	  as	  nucleoli	  and	  mitochondria	  (Fig	  8A)..	  The	  R	  loop	  increase	  seems	  to	  parallel	  the	  Top1cc	  formation	  and	   the	   post-­‐transductional	  modifications	   of	   Top1,	   as	   detected	   by	   ICE	   bioassay,	   a	  technique	   that	   allow	   isolating	   protein	   covalently	   bound	   to	   DNA.	   Top1	   results	  entrapped	  on	  DNA	  within	  few	  minutes	  and	  this	  phenomenon	  partially	  overlaps	  with	  burst	   of	   R	   loop	   structures	   (Fig	   8D).	   Interestingly,	   R	   loops	   	   	   show	   a	   peak	   in	  fluorescence	  at	  2’-­‐5’	  of	   treatment	  and	  then	  a	  decrease	  at	   longer	  time	  (1h)(Fig	  8B),	  while	  Top1cc	   continues	   to	   increase	  up	  20’	   even	   though	   the	  experiments	  were	  not	  quantitative	  (Fig	  8c).	  Similar	   dynamics	   were	   found	   for	   different	   cell	   types:	   HCT116,	   HEK293,	   Ntera2,	  NHDF	   (Fig	   8d).	   In	   all	   cases	   the	   increase	   was	   detected	   clearly	   at	   nucleoli	   and	  mitochondria,	  in	  a	  manner	  that	  seems	  to	  be	  general	  and	  pervasive.	  At	  nuclear	  level	  CPT	   seems	   to	   induce	   the	   formation	   of	   hot	   R	   loops	   foci	   detected	   in	   IF	   as	   strong	  brilliant	  dots.	  Altogether,	  the	  data	  suggest	  that	  Top1	  poisoning	  increases	  cellular	  R	  loops,	  but	  then	  these	  structures	  are	  rapidly	  removed.	  
	  
	  
3.2.3	  	  R	  loops	  in	  genomic	  DNA	  from	  cells	  treated	  with	  CPT	  are	  highly	  	  
	  	  	  	  	  	  	  	  	  	  	  unstable	  	  and	  difficult	  to	  isolate	  Immunofluorescence	  results	  showed	  clearly	  that	  poisoning	  of	  Top1	  by	  CPT	  induced	  a	   transient	   increase	   of	   R	   loop	   structures	   at	   cellular	   level.	   Thus,	   we	   wondered	  whether	   such	   an	   increase	   could	   also	   be	   detected	   at	   specific	   gene	   loci	   and	   at	  bidirectional	  CpG-­‐island	  promoters	  showing	  an	  increase	  of	  antisense	  transcripts.	  To	  this	   end,	   we	   decided	   to	   directly	   measured	   R	   loop	   formation	   at	   selected	   genomic	  regions	   by	   DRIP	   technique.	   In	   collaboration	   with	   Frederic	   Chedin’s	   Lab	   we	   first	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Fig	  9.	  R	  loops	  recovery	  after	  CPT	  treatments	  is	  impaired.	  DRIP	  qPCR	  analysis	  measuring	  levels	  of	  R	  loops	  in	  control	  and	  CPT	  treated	  cells.A	  )	  Time	  course	  with	  500	  nM	  CPT	  up	  to	  4h	  in	  Ntera2	  cells.	  B)	  Time	  course	  with	  10	  μM	  	  CPT	  up	  to	  1	  h	  in	  Ntera2	  cells.	  C)	  Effects	  of	  2’	  of	  treatments	  with	  10	  μM	  CPT	  on	  NTera2	  and	  NHDF	  cell	  lines.	  SNRPN	  and	  YW81	  are	  negative	  loci	  for	  R	  loop	  formation	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  Strikingly	   we	   found	   a	   great	   decrease	   of	   DNA/RNA	   hybrids	   at	   all	   the	   tested	   loci	  positive	  for	  R	  loops	  formation	  and	  for	  all	  the	  tested	  times	  of	  treatment	  (Fig	  9).	  This	  data,	  in	  clear	  contrast	  with	  IF	  results,	  suggested	  to	  us	  the	  charming	  hypothesis	  that	  Top1	   inhibition	  could	   lead	   to	  a	  distribution	  of	  R	   loops	  with	  a	  disappearing	  of	  classical,	  well	   characterized	  R	   loops	  and	  an	  arise	  of	  new	  R	   loops	  structure.	  Before	  performing	  DRIP	   analysis	   coupled	   to	  NGS	  we	  wanted	   to	  be	   sure	   that	   the	   increase	  detected	   in	   IF	   could	   be	   still	   detectable	   on	   genomic	  DNA	   extracted	   from	   same	   cell	  lines	  and	  same	  CPT	  treatments.	  We	  set	  up	  a	  protocol	  of	  dot	  blot	  to	  measure	  general	  level	  of	  R	  loop	  contents	  in	  genomic	  DNA	  extracted	  from	  control	  cells,	  using	  the	  s9.6	  ab	  to	  detect	  RNA/DNA	  hybrids.	  Fig	  10	  shows	  that	  R	  loop	  contents	  in	  genomic	  DNA	  extracted	  from	  cells	  treated	  with	  CPT	   10	   μM	   for	   2’	   decrease	   of	   about	   95%	   compare	   to	   control.	   These	   results	  were	  obtained	   at	   all	   the	   tested	   CPT	   concentrations	   and	   times	   of	   treatment	   (data	   not	  shown).	  
	  	  	  	  This	  data	   still	   in	   contrast	  with	   IF	   results	   lead	  us	   to	   consider	   the	  possibility	   that	  R	  loop	  structures	  after	  CPT	  treatment	  could	  be	  really	  unstable	  during	   the	  extraction	  step.	  The	  type	  of	  lysis	  used	  (TE-­‐SDS	  1%)	  leaves	  DNA	  with	  many	  Top1ccs,	  that	  after	  proteinase	  K	  become	  single	  strand	  breaks	  (SSBs).	  The	  treatment	  with	  proteinase	  K	  and	  the	  following	  nucleosome	  removal	  and	  the	  restriction	  enzymes	  activity	  used	  in	  
Fig	  10.	  R	  loops	  extraction	  is	  overall	  affected	  by	  CPT	  treatments.	  Dot	  blot	  analysis	  using	  s9.6	  ab	  performed	  on	  genomic	  DNA	  extracted	  from	  Ntera2	  cells	  treated	  for	  2’	  with	  10	  μM	  CPT	  	  
	   	   55	  




3.2.4	  Top1	  knockdown	  induces	  genome	  wide	  increase	  of	  R	  loop	  	  
	  	  	  	  	  	  	  	  	  	  structures.	  As	  genome	  wide	  mapping	  of	  CPT-­‐induced	  R	  loops	  looked	  to	  be	  out	  of	  our	  possibility	  based	  on	  current	  DRIP	  techniques,	  we	  then	  focused	  our	  effort	  to	  determine	  the	  role	  of	  Top1	  in	  R	   loop	  stability.	  With	  a	  siRNA	  approach	  we	  decided	  to	  understand	  how	  downregulation	   of	   Top1	   may	   affect	   R	   loops	   distribution	   and	   stability.	   We	   first	  decided	   to	   check	   if	   Top1	   depletion	   induced	   general	   increase	   in	   R	   loops	   cellular	  contents.	   Figure	   11	   shows	   dot	   blot	   analysis	   on	   genomic	   DNA	   extracted	   from	  HEK293	   control	   and	   double	   transfected	   with	   scramble	   siRNA	   or	   Top1	   specific	  siRNA.	  Top1	  depletion	   leads	   to	  an	  overall	   increase	  of	   about	  2-­‐3	   times	  as	   compare	  with	  scramble-­‐transfected	  cells.	  These	  data	  are	  a	   first	  evidence	  that	  To1	  may	  have	  an	  important	  role	  in	  the	  stability	  of	  DNA/RNa	  hybrids	  in	  living	  cells.	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  Interestingly	   only	   a	   double	   knockdown	   of	   Top1	   increase	   R	   loops	   levels,	   while	   a	  single	  round	  of	   transfection	  did	  not	  change	  DNA/RNA	  hybrids	  abundance,	  even	   in	  the	  presence	  of	  a	  reduction	  of	  Top1	  of	  about	  90%	  (Fig11).	  Therefore,	  performing	  a	  second	   round	   of	   downregulation	   on	   the	   remaining	   10%	   of	   Top1	   could	   induce	   an	  additional	   decrease	   of	   Top1	   protein	   level	   with	   percentage	   of	   remaining	   protein	  almost	   undetectable.	   Therefore	   downregulated	   levels	   of	   Top1	   have	   to	   be	   close	   to	  100%	  to	  stress	  R	  loops	  homeostasis.	  However,	  the	  limit	  of	  resolution	  given	  by	  WB	  analysis	  cannot	  assess	  the	  exact	  protein	  levels.	  	  	  
Fig	  11.	  Double	  Top1	  knockdown	  induces	  overall	  increases	  of	  R	  loops	  strucutures.	  A)	  Dot	  blot	  analysis	   	  using	  s9.6	  ab	  performed	  on	  genomic	  DNA	  extracted	  from	  HEK293	  cell	  control,	  double-­‐transfected	  with	  Top1	  specific	  siRNA	  or	  non	  targeting	  siRNA	  .B)	  Western	  blot	  analysis	  assessing	  Top1	  downregulation	  	  
B 
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  Another	   possibility	   is	   that	   R	   loop	   homeostasis	   could	   	   show	   time-­‐dependence	   for	  absence	  of	  Top1.	  Performing	  a	  double	  knockdown	  lead	  cells	  to	  be	  depleted	  for	  Top1	  for	   about	   72	   hours,	  while	   a	   single	   round	   leave	   cells	  with	   reduced	  Top1	   levels	   for	  only	  24	  hours.	  Anyway	  these	  data	  show	  Top1	  tightly	  regulates	  genomic	  R	  loops.	  	  
	  
3.2.5	  Genome	  wide	  mapping	  of	  R	  loop	  structures	  after	  Top1	  	  
	  	  	  	  	  	  	  	  	  	  	  knockdown	  Once	  we	  were	  able	  to	  detect	  a	  clear	  and	  strong	  effect	  of	  Top1	  depletion	  on	  R	  loops	  abundance	  we	  decide	  to	  perform	  DRIP-­‐seq	  and	  DRIPc-­‐seq	  analysis	  to	  map	  genome	  wide	   these	   structures	   and	  understand	  which	   genes	  were	  mainly	   affected	  by	  Top1	  depletion,	   in	   terms	   of	   R	   loop	   contents.	  We	   were	   also	   interested	   on	   what	   kind	   of	  modification	  is	  induced	  on	  these	  structures	  by	  Top1	  knockdown.	  DRIP	   and	   DRIPc	   are	   similar	   techniques,	   with	   some	   important	   differences.	   The	  former	   isolates	  and	  sequence	   the	  DNA	  that	  compose	  an	  R	   loop	  structure,	  whereas	  the	   latter	   is	   a	  derivative	   that	  allow	   to	   isolate	   the	  RNA	  molecule	   that	   is	  part	  of	   the	  hybrid	   resulting	   in	   a	   higher	   resolution	   and	   lower	   background.	  Additionally	  DRIPc	  
Fig	  11.	  Single	  Top1	  knockdown	  does	  not	  induce	  overall	  increases	  of	  R	  loops	  strucutures.	  A)	  Dot	  blot	  analysis	  	  using	  s9.6	  ab	  performed	  on	  genomic	  DNA	  extracted	   from	  HEK293	  cell	   control,	   	   trasfected	  with	  Top1	  specific	  siRNA	  or	  non	  targeting	  siRNA	  (one	  round	  of	  transfection).	  B)	  Western	  blot	  analysis	  to	  assess	  Top1	  kd.	  	  
	   	   58	  
maintains	  strand	  specificity	  and	  can	  thus	  distinguish	  between	  sense	  and	  antisense	  R	  loops.	  We	  first	  performed	  DRIP	  analysis	  on	  genomic	  DNA	  usedfor	  dot	  blot	  analysis	  shown	  in	   Figure	   10a.	   Immunoprepicitated	   DNA	   was	   then	   used	   to	   build	   library	   and	   was	  sequenced	  trough	  Illumina	  Solexa	  Deep	  sequencing.	  Table1a	  shows	  some	  statistics	  about	  quality	  of	  the	  sequencing	  :	  	  
A	  	  	  	  
DRIP-­‐
seq	  





Control	   48443728	   43264912	   41153979	   95.12%	  
Scramble	   53960771	   49287510	   46257679	   93.85%	  




Control	   47539735	   42771663	   34583165	   80.86%	  
Scramble	   50107377	   45319172	   35633207	   78.63%	  
Top1	  kd_1	   53789320	   48520636	   43697302	   90.06%	  
Top1	  kd_2	   53090435	   48430021	   42531238	   87.82%	  
	  Through	  peak	  calling	  analysis	  we	  were	  able	   to	   identify	  a	  comparable	  number	  of	  R	  loop	  peaks,	  with	   slight	   differences	   for	  Top1	  kd	   sample.	  Notably,	   number	   of	   peaks	  was	  minor	   in	   Top1-­‐downregulated	   cells,	   and	   this	   demonstrates	   that	   the	   increase	  following	   Top1	   depletion	   detected	   by	   dot	   blot	   analysis	   cannot	   be	   explained	   with	  raising	  of	  new	  R	  loop	  structure.	  	  	  	  	  
Table1.	  Number	  	  of	  total,	  clean	  and	  mapped	  reads	  for	  A)	  DRIP-­‐seq	  and	  B)	  DRIPc-­‐seq	  data	  




sample	   #	  of	  peaks	   #	  gain	  of	  peaks	  
(Top1	  vs	  Sc)	  
#	  loss	  of	  peaks	  
(Top1	  vs	  Sc)	  
Control	   54934	   /	   /	  
Scramble	   57456	   /	   /	  




Control	   64444	   /	   /	  
Scramble	   67732	   /	   /	  
Top1	  kd_1	   65795	   8340	   5725	  
Top1	  kd_2	   60517	   2536	   2938	  	  	  Interestingly,	  Top1	  knockdown	  lead	  to	  a	  redistribution	  of	  R	  loop	  structures,	  with	  a	  loss	   of	   R	   loop	   peaks	   in	   2141	   loci	   and	   appearance	   of	   2180	   new	   r	   loop	   peaks	  (table2A).	  Notably	  these	  re-­‐distributed	  structures	  were	  enriched	  in	  particular	  genic	  regions:	  particularly	  we	  found	  that	  gain	  of	  peak	  mainly	  occurs	  in	  gene	  body,	  while	  loss	  of	  peak	  was	  a	  feauture	  of	  3’	  end	  of	  genes	  (data	  not	  shown).	  We selected two loci 
that show gain of peak (HIF1A, EEIF1A1 and four loci that show loss of peak (Fig12) 
and we validated them in DRIP qPCR, All the selected regions showed a good agreement 
with sequencing data (Fig13). 
On the base of these interesting results we wanted to take advantage of the potential of 
DRIPc technique (higher resolution, minor background and strand information) and we 
decided to perform DRIPc-seq on two different biological replicates. Peak calling 
analysis identified a comparable number of peaks for all sample (table 2b) . Top1 
knockdown leads to loss of 1798 peaks and appearing of 1658 new peaks (shared for both 
replicate). Again, in agreement with DRIP-seq data, we found that the increase detected 
by dot blot analysis in Top1 kd sample cannot be due to rising of new R loop structures in 





Table	  2.	  Number	  of	  peaks	  in	  each	  sample	  for	  A)	  DRIP-­‐seq,	  B)	  DRIPc-­‐seq	  data	  











Fig12.Loci	  selected	  for	  validation	  of	  sequencing	  data	  by	  DRIP-­‐qPCR.	  Screenshots	  from	  UCSC	  genome	  browser	  of	  the	  selected	  
loci:	  Gain	  of	  peaks	  (A,B)	  and	  Loss	  of	  Peaks	  (C,D,E,F,	  also	  on	  following	  page).	  The	  red	  bars	  represent	  gains	  of	  peaks	  recognized	  by	  
peak	  calling	  software,	  the	  blue	  are	  the	  losses.	  Amplicons	  used	  for	  validation	  in	  DRIP-­‐qPCR	  are	  shown	  as	  black	  and	  white	  bars.	  
Red	  peaks	  are	  on	  positive	  strand,	  blue	  on	  negative	  strand.	  












Fig12.Loci	  selected	  for	  validation	  of	  sequencing	  data	  by	  DRIP-­‐qPCR.	  Screenshots	  from	  UCSC	  genome	  browser	  of	  the	  selected	  
loci:	  Gain	  of	  peaks	  (A,B	  previous	  page)	  and	  Loss	  of	  Peaks	   (C,D,E,F).	  The	  red	  bars	   represent	  gains	  of	  peaks	  recognized	  by	  peak	  
calling	   software,	   the	  blue	  are	   the	   losses.	  Amplicons	  used	   for	  validation	  in	  DRIP-­‐qPCR	  are	  shown	  as	  black	  and	  white	  bars.	  Red	  
peaks	  are	  on	  positive	  strand,	  blue	  on	  negative	  strand.	  





R loop can increase both in length and in 
frequency and these two phenomena 
could contribute to an overall and general 
increase. So, we first decided to measure 
and compare length of R loop total peaks. 
Box blot analysis showed in Fig 14, 
revealed that total peaks length 
distribution is significantly higher in 
Top1 depleted cells (P < 0,001 for both 
experiments).  By reporting length of 
peaks relative to frequency formation we 
found that these longer peaks are also 
more frequently formed after Top1 
depletion (Fig15). 
Fig	  14.Top1	  depletion	  leads	  to	  a	  spreading	  of	  R	  loops	  
structure.	   Boxplot	   analysis	   showing	   distribution	   of	  length	   od	   DRIPc	   peaks	   in	   samples	   Control,	   Scramble-­‐transfected	   and	   Top1	   depleted	   cells	   (two	   biological	  replicates).	  
Fig	  13.	  Validation	  of	  gain	  and	  loss	  of	  R	  loop	  peaks	  after	  Top1	  depletion.	  	  Six	  loci	  were	  selected	  fromsequencing	  data	  and	  assessed	  for	  R	  loop	  revovery	  by	  DRIp	  qPCR	  on	  genomic	  DNA	  extracted	  from	  control,	  scramble	  trasfected,	  or	  Top1	  deplted	  cells	  





Notably, difference in peak length can be 
detected even if we check distribution of 
peak’s length for only common peaks (top1 
vs scramble, Fig 16) demonstrating that 
increase in length is a genome wide effects, 
caused by change of common and classical R 
loop structures. We therefore concluded that 
Top1 depletion lead to spreading of common 
R loops across the genome. 
Considering that increase on average length 
was not more than 40% as compare to 
scramble sample, these results could only 
partially explain the doubling of r loops 
content detected by dot blot analysis. To 
understand if a reduced Top1 activity 
Fig15.	  Top1	  depletion	   increases	   frequency	   formation	  of	   longer	  R	   loops.	  Distribution	   of	  peaks	   length	  relative	   to	  frequency	  formation	  in	  Control	  ,	  Scramble,	  and	  Top1	  depleted	  cells	  (two	  biological	  replicates)	  










Length of common DRIPc peaks
bp
Fig15.	  Top1	  depletion	  induces	  spreading	  of	  common	  R	  
loops.	   Boxplot	   analysis	   showing	   averagd	   length	   of	  common	  peaks	  in	  control,	  scramble	  transfected	  cells	  and	  Top1	  depleted	  cells.	  
500 
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increases R loop formation frequency and in which part of genes this can occur, we 
performed metagene analysis. We calculated distribution of DRIPc signal in term of 
reads, around normalized genes. Every gene was divided in 10000 part to normalize each 
gene for its length, and DRIPc signal was used to generate a metaplot. Regions upstream 
and downstream to the gene body were also considered.  Fig 17 shows that Top1 depleted 
cell revealed an higher R loop signal in the entire gene body giving a proof of increased 






We then decided to focus on loci that showed gain and loss of R loops peaks after 
topoisomerase knockdown. We noticed that these genes were particularly stressed in 
terms of R loops modification after Top1 depletion, with a most pronounced effect . 
Metagene analysis, performed as prevoulsy shown, but using only genes that show gain 
of R loop peak, revealed that these new R loops are part of a general and very intense 
increase that involves the entire gene body (Fig 18 A). 
Fig	   17.	   	  Top1	   depletion	   induces	   genome-­‐wide	   increase	   of	   R	   loop	   structures	   in	   gene	  
body.	   Metagene	   analysis	   showing	   DRIPc-­‐seq	   reads	   distribution	   along,	   upstream	   and	  downstream	   of	   genes.	   Each	   gene,	   upstream	   region	   and	   downstream	   region	   was	  normalized	  on	  10000	  parts.	  	  






This data was confirmed also by peak location analysis that showed that gain of R loop 
peak are not randomly distributed in the genome, but are strongly enriched in gene body 
(73% of total distribution) (Fig 18b). Interestingly and differently from gain of peaks, 
when we focused on genes with loss of peaks after Top1 knockdown, metagene analysis 
revealed that loss of R loop mainly occurs at 3’ ends of genes (Fig 19a). Again, peak 
location analysis confirmed the same result showing an important enrichement at 
terminator sites (more then 30% of total distribution) (Fig 19b). We were really surprised 
to notice that the R loop profile on these genes is unusual compare to all the other genes, 
with an R loop peak really high at level of TTS (Fig 19a). These data suggest that 
probably loci tha show loss of R loop peaks after Top1 kd are a particular subset of genes 
with particular but unknown genes. 
 
A B 
Fig	  18.	  Gain	  of	  R	  loop	  peaks	  after	  Top1	  depletion	  occurs	  on	  the	  entire	  gene	  body.	  A)	  Metagene	  analysis	  of	  genes	  showing	  gain	  of	  R	  loop	  peaks	  after	  Top1	  kd.	  Each	  gene,	  upstream	  region	  and	  downstream	  region	  was	  normalized	  on	  10000	  parts.	  B)	  Peak	  location	  analysis	  showing	  genomic	  distribution	  of	  new	  R	  loop	  peaks	  induced	  by	  Top1	  depletion.	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We also noticed that genes that showed loss 
and gain of peaks were particularly long 
with many long introns. To confirm this 
hypothesis we checked averaged distribution 
of lengths of these genes. As controls we 
decided to analyze median length of all 
genes and all genes showing DRIPc peaks. 
As explained by boxplot in Figure 20, we 
found that genes with gain of peaks are 
incredibly longer than both all genes and all 
genes with DRIPc peaks (p < 2.2e-16). Same 
results, but in minor extent were found for 
genes that show loss of peak (p < 1.33e-13). 
This data is perfectly in agreement with the 
critical Role that Top1 has in regulating 
supercoil of really long genes (52). 
Since the directionality of transcription can 
generate different kind of torsional stresses, therefore affecting differently R loops, we 




Fig	   20.	   Top1	   depletion	   affects	   R	   loop	   homeostasis	  
particularly	  at	  level	  of	  really	  long	  genes.	  Boxplot	  with	  averaged	   distribution	   of	   length	   of	   all	   genes,	   all	   genes	  with	  DRIPc	  signal	  and	  gain	  and	  loss	  of	  R	  loop	  peaks.	  
	   	   67	  
wondered if gain or loss of R loop peaks could show a dependence on gene directionality. 
First, we checked on the genome browser UCSC the first 250 loci that show loss of peaks 
and the first 250 showing gain after Top1 knockdown. Then, we assigned them to one of 
the following categories according to the gene direction and genomic position: we 
defined two genes convergent when their TTS (transcription termination site) were 
colliding, unidirectional when their TSS showed same direction, divergent when gene 
direction and TSS showed opposite direction. We created a fourth category, for 
centromeric region, since these genomic loci were frequently represented in the group of 
loss of peaks but directionality cannot be assigned as they are untranscribed regions. 
Strikingly we found that loss of peaks was particularly enriched for convergent genes 
(67% of total) (Fig 21). Notably, when we focus on gain of peaks, the percentage of 
convergent genes drop to less than 30% and most represented class becomes the 














Fig.21.	   Loss	   of	   peaks	  mainly	   occurs	   at	   convergent	   genes.	   Pie	   chart	   of	   the	   distribution	  of	   250	   loci	  
showing	  loss	  of	  peaks	  according	  to	  gene	  direction.	  






To validate these data bioinformatically and at genome wide level, we decided to 
calculate genomic distances for these 4 categories: 
1) Distance from TSS to upstream TTS (unidirectional genes) 
2) Distance from TSS to upstream TTS (divergent genes) 
3) Distance from TTS to downstream TSS (unidirectional genes) 
4) Distance from TTS to downstream TTS (convergent genes) 
We decided to calculate these distances in the following groups: 
- All genes 
- All genes with DRIPc peaks 
- Genes with gain of peaks 
- Genes with loss of peaks 
The results are shown in Figure 23. First, we found that genes showing gain of R loop 
peaks were usually “alone genes”, very far from potential neighbors. This was seen for all 
the four analyzed categories (Fig23 A, B, C, D). Strikingly, focusing on loss of peaks, we 
found that, only in the category of colliding genes, these loci were particularly close to 
other genes, as compare to all convergent genes and all convergent genes with DRIPc 
peaks (40 kb for loss, 111 kb for all genes, 68 kb for all genes with DRIPc peaks). On the 









Fig.22.	  Gain	  of	  peaks	  after	  Top1	  depletion	  mainly	  occurs	  at	  unidirectional	  genes.	  Pie	  chart	  of	  the	  
distribution	  of	  250	  loci	  showing	  gain	  of	  peaks	  according	  to	  gene	  direction.	  






All these data revealed that Top1 could regulate R loop stability in different ways, 
probably dependently from different and specific genomic features. However, we wanted 
to better understand what is the effect of these R loop dynamics on gene expression. 
Additionally, determining gene directionality and therefore a possible positional effect on 
R loops dynamics needed that our data had to be filter for transcription levels. Moreover 
it was interesting to understand which class of genes (high, mild or low expression levels) 
was mainly affected by Top1 knockdown in terms of R loops contents. Finally, we also 
Distance	  from	  genes’	  TSS	  to	  upstream	  TTS	  (tandem	  genes)	   Distance	  from	  genes’	  TSS	  upstream	  TSS	  (divergent	  genes)	  
Distance	  from	  genes’	  TSS	  to	  downstream	  TSS	  (tandem	  genes)	   Distance	  from	  genes’	  TTS	  to	  downstream	  TTS	  (colliding	  genes)	  
	   	  	  	  	  	  	  	  All	  genes	  	  	  All	  DRIPc	  	  	  	  	  Gain	  	  	  	  	  	  	  	  Loss	   	  	  	  	  	  	  All	  genes	  	  	  All	  DRIPc	  	  	  	  	  Gain	  	  	  	  	  	  	  	  Loss	  
A	   B	  
C	   D	  
*	  
*	  
*	   *	  *	  
Fig	  23.	  Genes	  with	  loss	  of	  peaks	   tend	   to	  be	  convergent,	  while	  genes	  with	  gain	   tend	  to	  be	  isolated	  genes.	  Boxplot	  analysis	  showing	  distribution	  of	  distances	  between	  genes	  unidirectional	  (a	  and	  c),	  divergent	  (b)	  and	  convergent	  (d).	  *	  =	  at	  least	  to	  P<	  0.001	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wanted to correlate modifications in R loops with change in RNA Polymerase II 
distribution. To obtain all these information we performed RNAseq and PoII-ChIPseq in 
cells double transfected with scramble siRNA or depleted for Top1. Bioinformatics 
analysis on these genomic dataset is not completed yet. However we can still make some 
interesting conclusion by checking our data on UCSC genome browser. However these 
observations have to be obviously confirmed on large scale by bioinformatics analysis. 
As a first step, we focused only on gain and loss of peaks. Strikingly, we found that 
transcription and PolII distribution were not particularly affected for gene showing gain 
of R loop peaks (data not shown). Notably the case was different when we focused on 
genes showing loss of peaks. PolII distribution seemed to be affected mainly at 3’ end of 
these genes, in Top1 depleted cells. In particular, the peak of PolII typically seen at 
terminator pausing site resulted shifted of few kilobases upstream of TTS. Downstream 
of this region, in correspondence of the effective loss of peaks and further downstream, 
PolII seems to reduce progressively. Upstream of terminator site PolII occupancy doesn’t 
seem to decrease and in some cases even an increase can be detected (Fig 24a, b, upper 
part of the panel). These data suggest that probably, in the presence of a loss of peak, 
PolII stucks at level of TSS. RNAseq data were at first sight of difficult interpretation. 
FPKM calculation restricted only to genes with loss of R loops peaks did not reveal great 
change in expression level. However analysis on mapped reads distribution on the UCSC 
genome browser showed that specific changes in the RNA molecule happen at 3’ end of 
these genes. Particularly the last exon seems to decrease after Top1 knockdown. 
Additionally, RNA reads downstream of the 3’UTR always decrease (Fig 24 a.b lower 
panel). These reads (less in number compare to exon reads) are usually due to a 
polymerase that is loosing its processivity after transcribing the PolyA site, so could 
probably suggest potential impairment in the polyadenilation and termination process. 







	   	   71	  
 
	  
Fig	   24.	   Loss	   of	   peaks	   after	   Top1	   knockdown	   seems	   to	   correlate	   with	   a	   block	   of	   PolII	   at	   TTS	   and	   an	   impairment	   of	  
transcript	  specifically	  on	  last	  exon	  and	  in	  the	  termination	  regions.	  Screenshots	  from	  UCSC	  showing	  PolII	  distribution,	  R	  loop	  peaks	  and	  RNAseq	  reads.	  RNAseq	  data	  report	  the	  y	  axis	  to	  show	  the	  decrease	  in	  transcript	  level.	  A)	  TRMU	  gene,	  B)	  UCK2	  gene	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Chapter	  IV	  
	  
DISCUSSION	  	  	  In	   this	  work	  we	   investigated	   the	   role	   of	   two	   natural	   compounds	   Triptolide	   (TPL)	  and	   Campthotecin	   (CPT)	   and	   we	   characterized	   the	   effects	   of	   inhibition	   of	   their	  specific	  target	  (XPB	  and	  Top1)	  at	  transcriptional	  level.	  	  Particularly,	   as	   regards	  TPL,	  we	   tried	   to	  understand	   the	  mechanism	   that	  underlay	  the	  RNA	  Polymerase	  II	  stability	  during	  TPL	  treatments.	  We	  identified	  CDK7	  as	  a	  new	  molecular	  actor	  in	  the	  Rbp1	  degradation	  mechanism	  induced	  by	  TPL.	  As	   regards	   CPT,	   we	   tried	   to	   understand	   what	   are	   the	   consequences	   of	   Top1cc	  formation	   at	   actively	   transcribed	   regions,	   particularly	   at	   divergent	  promoters.	  We	  aimed	  our	  efforts	  to	  understand	  how	  Top1	  and	  its	  inhibition	  by	  CPT	  or	  its	  depletion	  affect	   the	  stability	  of	  R	   loops	  structures.	  Finally,	  we	  mapped	  R	   loops	  genome-­‐wide	  after	   Top1	   depletion	   and	   correlate	   R	   loop	   distribution	   changes	   with	   genic	  organization.	  The	   last	  part,	  performed	   in	   collaboration	  with	  Frederic	  Chedin’s	   lab,	  will	  need	  to	  be	  fully	  analyzed	  with	  other	  data	  such	  as	  expression	  data	  and	  genomic	  RNA	  Polymerase	  II	  maps.	  	  	  
4.1	  Triptolide	  and	  TFIIH	  Triptolide	   (TPL)	   is	   a	   strong	   transcriptional	   inhibitor	   whose	   mechanism	   of	   action	  and	  effects	  are	  not	  fully	  understood.	  The	   natural	   target	   of	   TPL	   is	   XPB	   an	   helicase	   which	   is	   part	   of	   the	   transcriptional	  factor	  TFIIH	  (33).	   	  TFIIH	   is	  a	  complex	  of	   ten	  subunits	  and	  among	  these	   it	   includes	  CDK7.	   TFIIH	   is	   a	   factor	   involved	   both	   in	   transcriptional	   initiation	   and	   nucleotide	  excision	  repair.	  Therefore,	  by	  inhibiting	  XPB,	  TPL	  blocks	  both	  transcription	  and	  NER	  pathway	  (33).	  Here	  we	  provide	  novel	  insights	  regarding	  RNA	  polymerase	  II	  stability	  during	  TPL	  treatments,	  showing	  new	  molecular	  aspects	  of	  the	  mechanism	  of	  action	  of	  the	  drug.	  Particularly	  we	  found	  that	  TPL	  triggers	  a	  CDK7-­‐mediated	  proteasome-­‐executed	  Rbp1	  degradation.	  We	  demonstrated	  that	  the	  time-­‐dependent	  degradation	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is	   preceded	   by	   a	   biphasic	   change	   of	   Ser5	   phosphorylation	   on	   CTD	   of	   PolII.	  Particularly,	  Ser5	  phosphorylation	  levels	  rise	  at	  short	  time	  of	  treatments	  (100	  nM	  2	  h)	  and	   then	  decline	  at	   longer	   time.	  This	  hyperphosphylation	   is	  mediated	  by	  CDK7	  and	  knockdown	  of	   this	   enzyme	   reverses	  both	  hyperphorylation	   at	   Ser5	   and	  Rbp1	  degradation	   induced	  by	  the	  drug.	   	  This	  suggests	   that	  Ser5	  phosphoprylation	   is	   the	  molecular	   signal	   responsible	   for	   PolII	   stability	   during	   TPL	   treatments.	   Some	  published	   reports	   are	   controversial	   about	   the	   hyperphosphorylation	   induced	   by	  TPL.	   Titov	   et	   al.,	   for	   example,	   did	   not	   find	   any	   change	   in	   phosphorylation	   level	  during	  TPL	   treatments	   (33).	   It	   is	  possible	   that	   their	   experimental	   conditions	   (200	  nM	   1	   h	   and	   4	   hours,	   A549	   cells)	   are	   not	   the	   optimal	   ones	   to	   detect	   the	   biphasic	  change	  on	  Ser5.	  Wang	  et	   al	  were	   instead	  able	   to	  detect	   the	  hyperphosphorylation	  events	   but	   not	   to	   identify	   either	   the	   site	   or	   the	   enzyme	   responsible	   for	   this	  hyperphosphorylation	   (32).	   Our	   data	   show	   that	   Ser2-­‐P	   levels	   do	   not	   change	   until	  late	   times	   of	   treatments	   (4-­‐6	   hours)	   when	   hypophosphorylated	   levels	   for	   this	  residue	   can	   be	   detected.	   These	   data	   suggested	   the	   possibility	   that	   the	   PolII	  elongation	   was	   in	   some	   ways	   affected	   during	   TPL	   treatments.	   ChIP	   experiments	  revealed	  that	  at	  really	  short	  times	  of	  treatment,	  PolII	  levels	  at	  active	  promoters	  are	  unaltered	  while	  on	   the	   corresponding	  exon	  a	   significative	  decrease	   can	  be	  overall	  detected.	  These	  data	  suggest	  that	  at	  short	  times	  of	  treatment	  TPL	  induces	  a	  block	  of	  RNA	  Polymerase	  II	  at	  class	  II	  promoters.	  IP	  experiments	  performed	   in	  collaboration	  with	  Ze	  Hong	  Miao’s	   lab	  demonstrated	  that	  TPL	   induces	  also	  ubiquitination	  of	  RNA	  Polymerase	   II	   (96).	   	  These	  data	  along	  with	  CDK7	  mediated	  hyperphosporylation	  of	  Ser5	  and	  block	  of	  RNA	  Polymerase	  II	  at	   promoters,	   lead	   to	   important	   considerations.	   The	   degradation	   of	   PolII	   after	  treatment	  with	   transcriptional	   inhibitors	   (alpha	   amanitin)	   or	  DNA	  damage	   agents	  (H202)	  was	  already	  previously	  showed	  (22).	  It	  seems	  that	  hyperphosphorylation	  of	  CTD	  can	  be	  a	  molecular	   signal	   to	   induce	  PolII	  degradation.	  Our	  data	   show	   for	   the	  first	  time	  that	  this	  mechanism	  can	  be	  valid	  also	  for	  inhibition	  of	  an	  helicase	  as	  XPB	  and	  its	  	  complex	  TFIIH.	  	  It	  is	  possible	  that	  inhibition	  of	  ATPase	  activity	  of	  XPB	  could	  impede	  promoter	  clearance	  of	  PolII.	  A	  stalled	  polymerase	  could	  be	  phosphorylated	  at	  CTD	  Ser5	  trough	  an	  activated	  CDK7	  leading	  to	  ubiquitination	  and	  degradation	  of	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the	   PolII	   largest	   subunit	   Rbp1.	   Alternatively,	   the	   hyperphosphorylation	   of	   Ser5	  residue	  after	  TPL	   inhibition	  of	  XPB	  could	   induce	  a	  PolII	   stalling	  and	  a	   consequent	  ubiquitination	   and	   degradation.	   However,	   additional	   experiments	   are	   required	   to	  understand	  if	  Ser5	  phosphorylation	  is	  the	  cause	  or	  the	  consequence	  of	  PolII	  stalling.	  	  TFIIH	  has	  also	  an	  ubiquitin	  ligase	  activity	  due	  to	  the	  presence	  of	  p44	  subunit	  in	  this	  complex.	  So	  TFIIH	  potentially	  possesses	  all	  the	  enzymatic	  activity	  (ATPase/helicase	  for	   XPB,	   kinase	   activity	   for	   CDK7	   and	   ubiquitin	   ligase	   activity	   for	   p44)	   that	   can	  mechanistically	   explain	   the	   molecular	   effects	   of	   TPL.	   In addition to the standard 
heptapeptide consensus sequence of Y1S2P3T4S5P6S7, there are several heptapeptide 
variants including variants containing a lysine residue in position 7 besides the serine 
residue in position 5. These sites could be the potential targets of the E3 ligase for 
ubiquitination (Lys7;  (97)) and Cdk7 for phosphorylation (Ser-5), respectively (Fig 25). 
Further investigations are necessary to identify the sites and the enzymes responsible for 
Rpb1 ubiquitination following TPL treatment.	  
 
 
Fig	  25.	  Model	  for	  the	  mechanism	  of	  action	  of	  Triptolide.	  Figure	  from	  Manzo	  SG,	  Zhou	  ZL,	  Wang	  YQ,	  Marinello	  J,	  He	  JX,	  Li	  
YC,	   Ding	   J,	   Capranico	   G,	   Miao	   ZH.Natural	   product	   TPL	   mediates	   cancer	   cell	   death	   by	   triggering	   CDK7-­‐dependent	  
degradation	  of	  RNA	  polymerase	  II.	  Cancer	  Res.	  2012	  Oct	  15;72(20):5363-­‐73.	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Our work show that TPL possesses distinct properties that makes this drug unique 
compare to all the other already-known transcriptional inhibitors (23). In conclusion TPL 
could serve as a powerful tool to investigate the regulation and function of TFIIH, and act 
as a model compound for anticancer drug development specifically targeting initiation 
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4.2	  Camptothecin,	  Top1	  and	  R	  loops.	  
Our data revealed a new and unexpected role of Top1 in regulating transcription. 
Particularly we found that pharmacological inhibition of Top1 by camptothecin (CPT) 
deregulates transcription rates at divergent CpG Island promoters favoring the 
enhancement of antisense transcription. We found that transient and stable knockdown of 
Top1 reduces the CPT induced-antisense transcription. Interestingly, simple Top1 
depletion by RNA interference does not induce antisense activation, suggesting that this 
phenomenon is mainly caused by Top1cc formation and not simply by reduction of Top1 
activity. Surprisingly the phenomenon seems to be replication independent since the co-
treatment with DNA Polymerase inhibitor aphidicolin does not suppress antisense 
transcripts. Divergent transcription has been reported in several eukaryotic cells. For 
example it has been shown that the majority of TSSs in murine embryonic stem cells are 
characterized by an active bidirectional transcription (98). Divergent transcription is a 
tightly regulated process, with the involvement of different factors. The positive 
transcription elongation factor PTEF-b has been found to play a critical role in regulating 
antisense transcription (98). Here we found that downregulation of CDK9 reduces CPT-
induced antisense transcription.  
CDK9 depletion and its pharmacological inhibition by DRB both reduce antisense 
transcript level, but they do not totally suppress CPT induced-enhancement of them. 
These data suggest the possibility that antisense transcript could be the result of a 
degradation impaired by CPT treatment. Interestingly, the reduction of the RNA 
degradation pathway by downregulating exosome components can increase promoter 
associated antisense transcription in mammalian cells (99). Further investigations need to 
be done to assess potential functional interaction between Top1 and exosome pathway. 
Another possibility is that Top1 inhibition by CPT could impair promoter directionality 
by interfering with the U1/PAS pathway. It has been shown that biderectionality of 
promoters is regulated by two important elements: a polyadenilation signal (PAS) 
upstream of TSS and a U1small nuclear ribonucleoprotein (snRNP) recognition site 
downstream of TSS (100). The PAS signal upstream induces early termination and 
cleavage of the antisense transcript, while the U1 binding site promotes correct 
transcription and suppresses early termination in the “sense” direction. Intriguingly, 
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interference with the U1 snRNP unbalances this mechanism, by inducing early 
termination in the sense direction and increased antisense transcription upstream of TSS 
in a manner really similar to what we saw for CPT treatment (95), (100). Strikingly, Top1 
inhibition by CPT has been shown to affect phosphorylation and activity of U1 snRNP 
(101), (102). 
The antisense transcription induced by CPT seems to be a specific consequence of 
Top1ccs. These complexes are rapidly formed during CPT treatment. Our results show 
that 2’ of treatment with high doses of camptothecin are enough to detect clearly Top1cc 
formation (Fig 8). Strikingly, Top1cc formation parallels an increase of non B DNA 
structure called R loops at highly transcribed regions such as nucleoli and mitochondria, 
in all the tested cell lines. Differently from Top1cc that constantly increase during CPT 
treatments, R loops stabilized by Top1 inhibition show a biphasic change with rising at 
short time of treatments (2-10’) and decreasing at longer times (1 hour). These data 
suggest that R loops during camptothecin treatments are rapidly removed after an initial 
stabilization, probably because they are dangerous structures for cell. However, some R 
loops foci remain relatively high until later stage (Fig 8a) suggesting that cells are not 
able to remove these structures at all genomic sites. The nature of these foci remains 
unclear. Moreover, during Top1cc formation due to CPT, Top1 is heavily modified 
trough sumoylation and ubiquitination (59 and Fig 8). One possibility is that R loops 
stabilized by CPT decrease following Top1 modifications and degradation, being in this 
way, a crucial part of Top1cc repair pathway. Howecer, how these modifications and if 
potential removal of Top1 by proteasome could play a role in R loops resolving has to be 
elucidated. 
R loops could be a link to bidirectionality of promoters too. First, a bidirectional 
promoter is probably characterized by relative high levels of negative supercoiling, 
generated by two molecules of RNA polymerases that transcribe in opposite directions.  
This condition could thermodynamically favor R loop formation. Second, by analyzing 
DRIPc data we found that bidirectional promoters show presence of antisense R loops 
upstream of TSS and that some of our antisense transcripts overlap to DNA segments 
known to form R-loops. Additionally 185 of 246 promoter-associated antisense 
transcripts overlap with or are within 3000 bp distant from an R loop-prone region (GC 
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skewed region). Recently it has been shown that R loops promote efficient termination of 
transcription at 3’ ends of genes by inducing repressive epigenetic marks (88). As 
mentioned above, bidirectional promoters usually show a PAS sequence upstream of TSS 
to early terminate antisense transcription. Notably U1 binding site sequence is highly GC 
skewed (Frederic Chedin, personal communication), therefore prone to R loop formation. 
Top1 inhibition could in some way interfere with this pathway via R loop, therefore 
inducing antisense transcription. Unfortunately the impossibility to isolate and map R 
loops following CPT treatments, with current genome wide techniques (DRIP, DRIPc) 
limits a lot the possibility to clarify and connect Top1cc formation with R loop and 
antisense transcription. 
The difficult to isolate R loops from cells treated with camptothecin merits few 
considerations. IF results showed clearly the increase of R loops after CPT treatment. 
Thus, why cannot we isolate the structures following CPT treatment? The first 
explanation is that the presence of SSBs derived from Top1 cc could make the R loops 
really unstable. In literature it has been shown that the presence of a nick on the non-
template DNA can favor R loop formation leading the RNA (65) to displace the non-
template DNA, but how much stable is an R loop in the presence of a partially broken 
DNA is not understood. Additionally, in transcribed regions Top1 cuts on the DNA 
template strand with a certain preference (L. Baranello and D. Levens, personal 
communication). Nobody knows how a nick on template DNA can affect R loops 
stability. Probably, the action of proteinase K and restriction enzymes used in DRIP 
protocol could lead to an unwinding of the R loop, driven by processes such as 
nucleosome removal and DNA endonucleasic cleavage.  However, further work needs to 
be done to define this topic.  
Although mapping of R loops structure following CPT treatments resulted out of our 
possibilities Top1 depletion experiments revealed important findings. First, R loops 
increase significantly in absence of Top1 (Fig 11). It is interesting that a single round of 
knockdown does not alter R loops levels, even in the presence of a strong reduction of 
Top1 (Fig 11). Notably, this effect can be detected only after a double knockdown. 
However, we probably found the way to critically downregulate Top1 and see an effect 
on R loop contents. DRIPc-seq analysis revealed really interesting results, some of them 
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totally unexpected. The first remarkable result is that Top1 depletion does not induce 
arising of new R loops structures in new loci. The number of peaks identified in each 
sample, which resulted really comparable, can prove this. Considering this data and the 
high increase detected by dot blot analysis, it looks that the increase of R loops structure 
after Top1 depletion is mainly a consequence of a stabilization and increase of frequency 
formation of preexisting R loops (Fig 15-16). Notably, R loops can also increase in length 
after Top1 depletion suggesting that an increased negative supercoiling state can favor a 
further reannealing of the nascent transcript therefore extending a pre-formed R loop.  
Metagene analysis revealed that Top1 depletion increases R loop frequency at a genome 
wide level. Surprisingly, this phenomenon regards the entire gene body. These data is 
completely new and totally unexpected and show a general role for Top1 in regulating R 
loops. Tuduri et al (70) demonstrated that Top1 depletion lead to interference between 
transcription and replication fork, resulting in an S-phase specific genomic instability. 
Notably, these effects are reverted in the presence of an overexpression of RNAseH, 
suggesting an involvement of R loops structures (70).  However, they did not provide 
direct evidences of an increase in R loop contents. Here we showed for the first time that, 
overall, Top1 depletion effectively stabilize R loops and that their frequency formation is 
increased in the entire gene body, whereas R loops levels remain quite similar to controls 
in promoter and terminator regions (Fig 17). During top1 knockdown experiments, we 
noticed a reduction in the doubling times for these cells, concordantly with the slowed 
replication forks and alteration of S-phase reported by Tuduri et al (70). It will be really 
intriguing to understand what is the consequence of an R loop stabilized by Top1 
depletion in cell cycle phases other than S phase. 
It is really interesting that R loops stabilized in the presence of CPT are rapidly removed, 
while Top1 depleted cells show increase of R loop structures for long times (up to 96 
hours after second round of transfection, data not shown). We think that Top1 inhibition 
by CPT and Top1 depletion by siRNA have different effects, with R loops stabilized by 
CPT being definitively more dangerous and therefore rapidly removed. Further 
investigations and characterization of R loops stabilized by CPT with genome-wide 
techniques are needed to establish the exact molecular events and mechanisms. 
We were really surprised to find some loci that looked particularly stressed in terms of R 
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loop contents as we have found regions with “new” or “lost” R loops after Top1 
knockdown. However these R loops are not unique and isolated structures that appear or 
disappear after Top1 knockdown, but they look as a part of a change in length and 
frequency formation in pre-existing R loops (Fig 12).  
Particularly, as regards new R loop peaks, this phenomenon seems to be part of a general 
increase in frequency and a spreading along the entire gene length and further 
downstream and upstream (Fig 12A and B). Genes showing gain of R loop peaks resulted 
the ones with the biggest increase in R loop formation frequency (compare Fig 18 with 
Fig 17 and 19), so they are probably the most affected by the Top1 depletion in terms of 
R loops contents. Again, the increase in R loops involves the entire gene length. These 
genes resulted to be really long compare to average length of genes with DRIPc signal. 
Top1 has been seen to be critical for transcription of really long genes (52). However, we 
did not find particular change in PolII distribution and RNA transcript levels for these 
genes (data not shown). Interestingly, from genomic positional analysis, these genes 
resulted to be really far from gene neighbors and mainly located in genes-poor regions. 
Helmrich et al. demonstrated that collision between replication and transcription 
machinery is inevitable for genes longer that 800 kb (as transcription of these genes spans 
more than the entire cell cycle) (103). Interestingly, these collisions seem to be the source 
of common fragile sites (CFS) and involve R loop formation. Genes with “gain” of peaks 
are not as long as genes studied in Helmrich’s works, but could still represent possible 
genomically unstable loci for the strong stabilization of R loops driven by Top1 
depletion. However, we did not identified DNA damage sites and therefore the role of 
Top1 on R loops and genome instability at these specific loci need further and 
investigations.    
Genes showing the loss of peaks after Top1 depletion resulted the most interesting, with 
completely unexpected results. Again, as it was for gains of R loops, these sites of R 
loops suppression seem to be part of modification of preexisting structures that change in 
shape after Top1 depletion. Loss of peaks usually coincides with a shortening of R loop 
molecule at 3’ end of the gene (see Fig 12 C for a clear example). Interestingly, it seems 
that upstream of the loss site R loops tend to increase (Fig 12 C, E, F) suggesting a 
possible contraction of the R loop on the entire gene length. Literature have always 
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consider Top1 as a “preventing R loop factor” due to its possibility to remove negative 
supercoils that usually favor R loop formation (65). Here, we show that the story is not as 
simple and that for a subset of genes this is not the case. Strikingly, the loss of peaks 
usually occurs at 3’ ends of gene (Fig 19), suggesting this phenomenon is specific for this 
region. The data are in agreement with the role that Top1 has in regulating supercoil 
during transcription, and may suggest that torsional stress created by transcription 
machinery accumulates at 3’ end of genes and cannot be dissipated due to the absence of 
Top1. Genes showing a loss of peaks resulted to be long genes, although in a minor 
extent as compare to genes with gain of peaks (Fig 20). Again, it seems that on this kind 
of genes Top1 could have a particular role. But why these two opposite effects (gain/loss) 
on similar genes? The answer probably comes when we focus to gene directions and gene 
distances. Surprisingly, genes showing loss of peaks resulted to be convergent genes (Fig 
21) and interestingly, their TTS are closer compare to average distance between all 
convergent genes with DRIPc signal (Fig 22). These data bring to light the possibility 
that suppression of R loops could be the consequence of hyperpositive supercoil 
accumulated in the convergence region. According to the twin supercoiled model, a 
transcribing RNA polymerase generates positive supercoil ahead and negative supercoils 
behind itself (42). In the case of a convergence region the positive supercoils generated 
by two colliding RNA Polymerase could be probably superimposed leading to a torsional 
stress particularly strong and difficult to dissipate. This, in case of Top1 depletion, could 
lead to R loops suppression. A particular consideration has to be done for a small subset 
of loci showing loss of R loop peaks: centromeric regions (Fig 21). It is not clear why 
Top1 depletion should lead to reduction of R loops in these loci, especially if we consider 
that are usually untranscribed regions. R loops have been show to play a role in 
maintaining eterochromatinic states (104), (105). It would be really interesting to 
investigate if Top1 plays a role in this process. We also have to consider the possibility 
that these losses of peaks at centromeric site could be an artifact of the sequencing, as 
repeated regions can introduce important bias in deep sequencing analysis (106). 
However, even excluding centromeric regions, genes with loss of peaks still remain the 
most interesting category in terms of R loops modulation induced by Top1 depletion. 
Metagene analysis revealed that these genes have a unique DRIPc profile, with a 
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distribution of R loops particularly high at TTS (Fig 19). R loops at terminator sites have 
been shown to play an important role in transcriptional termination process (19), (88), 
(89), R loop formation at terminator should slow down the elongating polymerase 
therefore favoring the termination process. Senataxin should then resolve the R loop 
formed at this region, favoring the Xrn2-mediated degradation o the RNA still attached to 
PolII (19). The presence of such high levels of R loops at loss of peak sites suggest that 
probably in these genes termination mechanism via-R loops is particularly reinforced. 
This correlates quite well with the observation that these genes are close to other 
convergent genes. Therefore, it seems that a good terminator site is required to avoid 
collision of convergent transcribing polymerases. 
But how Top1 depletion affects RNA polymerase II distribution and transcription at level 
of R loops loss sites? Although the bioinformatics analysis for our PolII-ChIP-seq and 
RNA-seq is not completed yet, we found important differences in these two parameters. 
Loci with loss of R loop at 3’ end of gene showed a decrease of PolII density downstream 
of the R loop loss site. Additionally, at level of TTS PolII paused peak seems to be 
shifted upstream of few kilobases in absence of Top1 (Fig 24). Therefore Top1 depletion 
seems to affect Pol II distribution at convergent genes. Notably PolII distribution does not 
change on genes with gain of R loops that resulted to be really long. So it seems that not 
only gene length (50), but also gene convergence and gene density can impair PolII 
progression in absence of Top1. The consequence of this impaired process involves also 
the efficient production of a transcript. Transcripts at level of R loop loss sites seem to 
decrease particularly at last exon (Fig 24). Notably even RNA seq signal downstream of 
the RNA 3’ UTR decreases after Top1 depletion. These data can be a possible additional 
evidence of an impairment of termination and polyadenilation. Additionally, it has to be 
considered that splicing of last exon and polyadenilation are strictly related (107) Our 
RNA-seq was performed on total RNA and not mRNA. A Total RNA sequencing is 
probably not the best approach to study effects on RNA molecules specifically at 3’ end 
of genes. Thus, it will be crucial to understand if polyadenilation is in someway affected 
in loci showing loss of R loop peaks. However, these results have to be confirmed and 
validated by further and several analyses.  
Another intriguing question arises if we consider the average gene distance between 
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colliding TTS of genes with loss of peak: 40 kb (Fig 23). Is it possible that torsional 
stress created by Top1 depletion in convergence region can act on such a long distance? 
It is hard to answer this question. Two studies have tried to characterize torsional stress 
linked to Top1 with psoralen photobinding. Both of them used campthotecin to inhibit 
Top1 (108) (119). Unfortunately these two studies focused their analysis on gene body 
without considering intergenic regions or gene direction. It will be useful to use these 
genomic data to see if Top1 inhibition increases positive supercoils in our R loop loss 
sites. 
Finally, we need to consider that all DRIPc data has to be filtered for gene expression 
levels. This allows us to identify unexpressed genes and determine with higher precision 
gene direction. Moreover, we will be able to understand how Top1 modulate R loops 
according to transcription level. 
With this work we provide new insights in the transcriptional role of Top1. We found 
new unexpected properties for its specific inhibitor CPT and we characterized the role 
Top1 in an unknown and poorly studied field such that one for R loops. Chedin’s  lab 
calculated that R loops are probably the most abundant class of non B DNA structure, 
probably covering the 5% of the genome. Most part of these structures is responsive to 
Top1 depletion. Therefore, it is unlikely that all of them simply contribute to genomic 
instability. It’s clear that there are dangerous R loops and physiological R loops, R loops 
that are rapidly removed and R loops well tolerated by cells’ control systems. Thus, a lot 
of work has to be done to correlate these structures to molecular interplayers, biological 
















In conclusion we found that TPL and CPT are exquisite tool to dissect the transcriptional 
role of their specific targets XPB and Top1. We disclosed new properties of the drugs and 
characterize the transcriptional effects of drug treatment, adding new insight on how cell 
system responds to these drugs. This work will also help to understand the physiological 
and the pathological role of important enzymes such as XPB and Top1. 
 
 
	  	  Top1 	  	   Top1 Top1 	  
	   	   	   H	  	   	   	   	  	  
Convergent	  long	  genes 
	   	  (-­‐) R	  loops 	   	  (-­‐) R	  loops 	   	  (+) R	  loops 
	   	   	   	  	   	  	   	   	   	  
Divergent/Unidirectional	  	  	  very	  long	  genes 
	   	  (-­‐) R	  loops 	  	  	   	  (-­‐) R	  loops 
Top1 	   Top1 	  
	  Block	  of	  PolII	  progression Impaired	  Polyadenilation	  ??? 
	  Genomic	  instability	  ??? 
Fig	  26.	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